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ABSTRACT
It is shown here that the ability of B lYmphocytes
to act as supportive host cells for virus infections
requires they be activated from the resting Go stage of
the cell cycle. I have used a series of activation
regimens, which allow B cells to progress to different
stages in their activation/differentiati pathway toward
antibody secretion, in order to evaluate the extent of
activation required to support vesicular stomatitis or
Newcastle disease virus infections.
At least three distinct phases during B cell
activation which affected VSV infection were defined.
Freshly isolated resting murine splenic B cells in the Go
phase of the cell cycle do not support VSV, assessed by
protein synthesis, infectious center formation, and PFU
production. Small B cells cultured for 48 hours without
stimulation still do not support VSV. B cells stimulated
with the lYmphokines found in Con A activated supernatants
from splenic T cells or cloned T cell lines transited into
the G1 phase of the cell cycle but remain refractory to
vsv. These VSV non-supportive B cell populations do take
up virus particles and transcribe viral mRAs which can be
translated in vitro , suggesting a translational block to
vii
VSV. B cells stimulated into the S phase of the cell
cycle with anti-immunoglobulin synthesize VSV proteins and
increased numbers of infectious centers , but only low
level PFU synthesis lPFU per infectious center) is
observed. Co-stimulation with anti-Ig and lYmphokines,
which supports differentiation to antibody secretion,
enhanced PFU synthesis without further increasing the
number of infected B cells. LPS , which activates B cells
directly to antibody secretion by a pathway different from
anti-Ig, induced infectious centers, and PFUs at levels
comparable to those seen when stably transformed
permissive cell lines are infected. Co-stimulation of LPS
activated B cells with the same lYmphokine populations
that enhance PFU production when anti-Ig is used as a
stimulator suppresses PFU production completely,
suggesting that anti-Ig and LPS activated B cells are
differentially responsive to lYmphokines.
NDV infection of murine B cells differed markedly
from VSV infection, as all B cell populations examined
gave a similar response pattern. NDV viral proteins were
synthesized by B cells in each of the activation states
previously described, even freshly isolated B .cells.
Infectious center formation increased up to 5-fold over
viii
the levels observed with unstimulated B cells after anti-
Ig or LPS activation. However, PFU synthesis was low (~1
PFU per infectious center) for all B cell populations.
These results suggest that these two similar
viruses may be dependent on different host cell factors
and that these factors are induced for VSV but not NDV by
the B cell activators employed here or that the process of
infection of B cell by these two viruses induces different
cellular responses.
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INTRODUCTION
Cells of the lymphoid lineage can be host cells
for infection by many viruses of all taxonomic groups: RNA
and DNA genomes , cytoplasmic and nuclear replication
patterns (review: McChesney and Oldstone, 1987).
suppression of immune system function is observed
coincidental with many acute viral infections in man and
animals , demonstrating one important consequence of
infection of immune system cells. Immune suppression may
have more physiological consequences for the host than the
infection of other organs and tissues , as it permits the
reactivation of other pathogens or allows opportunistic
infections to occur. Suppression may be direct , in that
infected lymphocytes are eliminated through virus-mediated
cytolysis , or indirect , whereby lymphocytes are
functionally altered through the loss of key
differentiated functions , such as has been shown to occur
for cytotoxic T cell activity or B cell antibody synthesis
(Rice et. al., 1984; Casebolt et. al. , 1987; Romano et. al.
1977; McFarland, 1974; Kleinerman et. al. , 1974; Whittle
et. al. , 1978). suppression of immune responsiveness
during virus infection could be the consequence of either
of these mechanisms. The focus of this dissertation is to
understand the events leading to viral parasitism of
lYmphocytes , to understand how the process of infection
procedes and what unique aspects of lYmphocyte biology
serve to enhance or suppress the viral infection.
One can envision a number of ways in which the
particular physiology of lYmphocytes can affect their
susceptibility as host cells for virus infection. The
ability to enter the target cell is a first requisite for
virus infection. Entry can be achieved both by specific
receptor mediated endocytosis or by non-specific
endocytotic events. The few virus receptors that have
been well characterized are cellular proteins involved
with other critical cell functions , for example: human
immunodeficiency virus predominately uses the CD4 molecule
on T lymphocytes for virus entry, a molecule critical for
MHC class II restricted cell: cell interactions (Fauci,
1988); Epstein-Barr virus uses the complement receptor CR2
(CD21), a molecule normally involved in B cell activation
(Cooper et. al. , 1988); and cellular adhesion molecules
such as ICAM-1 and other members of the immunoglobulin
superfamily of proteins , are receptors for rhinovirus
pOli.ovirus , and foot and mouth disease virus (Gr
et. al. , 1989; staunton et. al., 1989; Mendelson et. ale ,
1989; Acharya et. al. , 1989). Therefore , the presence of
receptors is a maj or determinant of cell tropism for
particular viruses.
An additional level of virus restriction involves
the susceptibility of the virus receptor to modulation.
Is the molecule constitutively expressed on a lYmphocyte
or does expression vary with the activation state?
Lymphocytes are normally found in a continuum of
activation states due to ongoing responses to
environmental antigens or infection. Before activation
both B and T lymphocytes are found as small cells in the
resting (Go) stage of the cell cycle , but following
antigen exposure they are driven into the G1 and S phases
of the cell cycle, causing increased cell size , increased
RNA and protein synthesis , and concurrent changes in
expression of cell surface antigens. Expression of a
virus receptor may therefore vary with the activation
state of the lymphocyte , which could not only det rmine
the presence or absence of a particular molecule , but also
its level of expression. Successful receptor mediated
- --.
endocytosis of a virus particle leading to infection may
require that a virus engag simultaneously a number of
receptor molecules. on the - host cell surface. That the
level of receptor expressi n is i portant and correlated
to a lymphocyte I s activation state is illustrated by the
finding that the EBV receptor , present on resting B cells
is down regulated from the B cell surface upon activation
to S phase of the cell cycle , making activated B cells
less susceptible to infection (Casali and Notkins , 1989).
Expression of a virus receptor may also be restricted to
particular cell types or subpopulations within a cell
type. For example, the CD4 receptor molecule for HIV is
expressed only on a subpopulation of T lYmphocytes.
Therefore , both the presence of a receptor as well as the
level of expression can affect the ability of a virus to
infect lYmphocytes.
A further restriction on virus infection is
imposed by the physiology of lymphocytes. It has been
repeatedly demonstrated that the ability of a lYmphocyte
to function as a host cell for a "productive" virus
infection requires activation from the resting state
(reviews: Wheelock and Toy, 1973; Bloom et. al. , 1976;
McChesney and Oldstone, 1987). For example, human
peripheral blood lymphocytes required mitogenic
stimulation to support measles virus infection
(Huddlestone et. al., 1980). Experiments done by Lucas
studying measles virus infection of human lymphocytes
(Lucas et. al. , 1978) and Romano studying vesicular
stomatitis virus (VSV) infection of mouse lYmphocytes
(Romano et. al. , 1977) attempted to show that the
requirement for activation was not at the level of virus
entry as unstimulated lymphocytes exposed to virus
produced infectious centers and PFUs upon subsequent
mitogenic activation. However, the ability of viruses to
enter resting lymphocytes could not be completely resolved
because the state of activation of the lymphocytes taking
up virus particles was not determined because the
lYmphocyte preparations examined were not depleted of
endogenously activated cells. In more recent experiments
resting Go human tonsilar B cells, isolated by size
fractionation , were shown to take up measles virus , as
these B cells upon subsequent activation with mitogens
produced measles antigens on the B cell surface and
produced PFUs (McChesney et. al. , 1987). Unfortunately,
these experiments fail to define the nature of the block
in virus infection in unstimulated lymphocytes or the
inductive signals necessary to drive resting primary B
lymphocytes to a state where they will support a virus
infection.
What evidence would suggest that the activation
state of the B cell can affect the outcome of a virus
infection? EBV can infect and transform normally short-
lived resting B lymphocytes into persistently infected
blast cell lines which express some early EBV antigens and
are capable of continuous proliferation. Further
stimulation (activation) of these cell lines by cross-
linking their surface immunoglobulin receptors with anti-
immunoglobulin antibody induces cellular changes that
result in a lytic EBV infection (Crawford and Ando , 1986).
These results , combined with the findings with measles and
VSV infections previously discussed , suggest that the
eventual outcome of a virus infection is affected by the
unique biochemical characteristics found in B cells in
different activation states. Moreover , efficient virus
replication may require unique host cell factors which may
only be present during a particular activation state or
available in a particular lYmphocyte lineage.
B cell activation and the induction of cellular
factors which alter B cell physiology are brought about by
engaging two classes of receptors , the receptors for
antigen or mitogens on B cells or receptors for
lYmphokines. stimulation of the antigen receptors on B
cells , either with speci ic antigen or in a polyclonal
fashion using anti-immunoglobulin (anti-Ig), or mitogen
. receptors , such as lipopolysaccharide (LPS), induce cell
enlargement and increased RNA and protein synthesis that
support entry into the S phase of the cell cycle.
Differentiation to antibody secretion is supported by LPS
activation alone , whereas anti-Ig stimulated B cells
require the support of lymphokines. Supplemental
signalling is provided by distinct lYmphokines that are
known to be active during different stages in the B cell
activation pathway (O'Garra et. al., 1988). This likely
reflects the regulated expression of distinct lymphokine
receptors and/or the ability to respond to distinct
lymphokines that is concurrent with stages of B lYmphocyte
differentiation. As with other powerful biological
mediators, lymphokines can have opposing effects on B
lYmphocytes e. the presence of interleukin-4 (IL-4)
enhances proliferation and the synthesis of IgG1 and IgE
whereas interferon-gamma suppresses proliferation and the
IgG1 synthesis induced by IL-4 while enhancing IgG2a
production in B cells co-stimulated with LPS (Snapper and
Paul , 1987). This observation suggests that the unique
biochemical changes produced by lymphokines during B cell
activation result from the induction of distinct genes
the products of which carry out diverse biochemical
reactions. Such changes are likely to affect the B cells
ability to support virus infection.
What models are available to assess virus
infection in lymphocytes which will permit a critical
evaluation of the impact of cellular activation on this
process? Previously, many investigators have used human
and murine lYmphoblastoid cell lines as stable models of
lYmphocytes in different lineages or differentiation
states for study. Non-permissive cell lines were used as
models for non-permissive primary cells in order to
investigate the nature of restrictions on virus infection
in lymphoid cells. Measles virus was shown to replicate
in eight human B and two T cell lines wi th equivalent
efficiency (Joseph et. al. , 1975). In contrast,
replication of VSV, another negative-strand RNA virus , in
a panel of human B lymphoblastoid lines (two of the same
lines analyzed in the study of measles infection) was
found to be restricted at the level of genomic
replication; VSV infection was not restricted in T cell
lines (Nowakowski et. al., 1973; Creager et. al. , 1981;
Johnson and Herman , 1984). Further analysis of human B
lYmphoblastoid lines revealed that VSV restriction could
be correlated with the presence of the EBV genome which
when present resulted in persistent rather than lytic VSV
infections. EBV negative B cell lines were totally
permissive for VSV , and cytopathic effects were seen
(Creager et. al., 1982). These results suggest that the
transforming event, which allows for proliferation without
, .
further differentiation of these human B cell lines , may
markedly influence the ability to support virus infection
and as such confound the attempt to correlate lymphocyte
differentiation with the process of infection.
Experiments with murine B cell lines which are
thought to closely approximate different stages in the B
cell activation/differentiation pathway similarly yielded
equivocal results. Experiments using a pre-B cell , an
immature B cell, as well as mature B cell lines showed
that all these cell lines were equally effective as
targets for VSV infection (Rup and Scott , 1987). I have
also shown that murine cell lines representing different
stages in B cell differentiation support VSV, as assessed
by infectious center formation and PFU synthesis (Table
1) . The pre-B cell line (70Z/3) and the B cell line
(BCL1), which represents an immature B cell that can be
further activated to antibody secretion, support VSV
infection 102 infectious centers and 000 PFU per 103
cells analyzed) as do the myeloma (SP2/0) and hybridoma
(36-65) cell lines which have characteristics of end stage
plasma cells. Freshly isolated or unstimulated cultured
primary B cells do not support VSV infection, assessed by
the same assays (Table 1), a result which is in agreement
with previous observations on the inability of unselected
",'::':
populations of resting lymphocytes to support virus
infection (reviews: Wheelock and Toy, 1973; Bloom et. al.
1976; McChesney and Oldstone, 1987). However, the
requirement for activation can readily. be seen ," as primary
B cells which have been activated for 48 hours with
lipopolysaccharide support an increase in both VSV
infectious centers and PFU synthesis. A further
complication in the use of cell lines for these studies is
that lYmphokines, which can directly affect virus
infection , may be secreted at high levels and in different
combinations by both B and T cell lines. Therefore,
whereas these cell lines may retain some of the
characteristics and response capabilities of B cells in
different stages of activation/differentiation , all B cell
lines tested support VSV , thus precluding their use as
critical models to assess activation induced changes in
cell function which effect the support of a virus
infection.
The studies presented here di;rectly address how
the process of lymphocyte activation in primary B
lymphocytes alters' the cellular response to virus
infection. I use as a model system populations of primary
resting murine splenic B cells in the Go phase of the cell
cycle which were enriched by depletion of T cells with
''' '''';
antibody and complement followed by counter-current
centrifugal elutriation so as to isolate small resting B
cells free of other cell types. B cells so isolated may
be stimulated to relatively physiologically homogeneous
stages in their activation/differentiation pathway (Figure
1) in an inducer dependent fashion. Lymphokine exposure
causes B cell blastogenesis with an increase in RNA and
protein synthesis , but does not cause proliferation. The
lymphokines to be used in activation studies were prepared
as cell culture supernatants (SN) isolated following Con A
activation of freshly isolated heterogeneous splenic T
cells or T cell clones. SNs so obtained contain different
populations of lymphokines and all support transit to the
G1 phase of the cell cycle (O'Garra et. al. , 1988; Paul,
1089) . In B cells cultured for 48 hours with various
lymphokine mixtures there was an average 3-4 fold increase
in protein synthesis , directly monitored by incorporation
of 35S-methionine, over unstimulated but cultured cells
(Table 2). B cell entry into the S phase of the cell
cycle can be induced by activation with anti-
immunoglobulin (anti-Ig) (DeFranco , 1987). This
stimulation causes a further increase in protein synthesis
on a per cell basis (Table 2). Activation with anti-Ig
and lYmphokines or lipopolysaccharide (LPS) represent the
. , . '
most rigorous B cell stimulation regimens , and, while both
support B cell differentiation to antibody secretion
(parker et. al., 1980; Howard et. al., 1982), they use
different cellular signalling pathways. Anti-Ig signals
through B cell antigen receptors in a polyclonal fashion
activating the phosphoinosi tide/protein kinase C pathway
(DeFranco, 1987), and LPS binds to another receptor on the
B cell and activates an uncharacterized G protein signal
transducing pathway (Lei and Morrison , 1988; Bright
et. al., 1990; Chen et. al. , 1990). B lYmphocyte
populations, activated in culture with the appropriate
inducers for 24 or 48 hours to different stages in their
differentiation pathway were assessed for their ability to
support virus infection.
The viruses chosen for this study are vesicular
stomatitis virus (VSV), a rhabdovirus , and Newcastle
disease virus (NDV), a paramyxovirus (Figure 2). Both are
enveloped negative-stranded RNA viruses which undergo
similar replication cycles in the cell cytoplasm af
being taken up by different routes. VSV is endocytosed
and the nucleocapsid subsequently released into the cell
cytoplasm when acidification of the endosome causes VSV-G
protein mediated fusion of virus membrane with the
endocytotic vesicle membrane. The NDV nucleocapsid is
released directly into the cell cytoplasm by fusion of the
viral membrane with the cell membrane mediated by the NDV-
F glycoprotein at neutral pH. Replication involves an
initial round of primary transcription of viral mRA' , 5
for VSV and 6 for NDV, carried out by the RNA dependent
RNA polYmerase (encoded by the L gene plus NS or NP)
associated with the nucleocapsid and packaged in the
virion. Primary translation of viral proteins uses the
host cell translation machinery and is followed by an
amplification of infection through replication of positive
sense genomic RNA molecules which function as templates
for negative sense genomic RNA synthesis. Assembly and
maturation of the virus particles occurs at the host cell
membrane (reviews Kingsbury, 1990; Wagner , 1990).
As these viruses encode few proteins, host cell
factors not yet completely defined play a role in the
process of infection (Emerson, 1985; Kingsbury, 1990).
Restrictions on virus infection can be envisioned to occur
at a numbe of stages in the virus replication cycle and
could result from the absence of critical host factors or
the presence of specific inhibitors.
In this dissertation VSV and NDV are used as
probes to analyze the ability of B cells in different
activation states to support infection. Chapter 1
- --- - ---
determines the B cell activation requirements necessary to
support vsv. In chapter 2 the molecular basis of VSV
restriction in non-supportive lymphokine stimulated B cell
populations is analyzed. These studies identify
translational control as one level of restriction. This
chapter also describes the modulating effect of
lymphokines on virus expression in B cells by showing that
lymphokine populations can both enhance and inhibit virus
replication, depending on the activation pathway used for
B cell induction. Chapter 3 examines the B cell
population which is partially supportive of VSV and begins
to examine additional levels of restriction on VSV
infection. Chapter 4 examines B cell support of NDV and
demonstrates that B lymphocyte activation requirements
established for one virus are not universal, even for
closely related virus families. Chapter 5 presents the
overall conclusions and suggested future directions.
Table and Fi ure le ends
Table 1
Analysis of B cell lines and primary B cells for
support of VSV infection. Cell lines were infected at a
i. of 10, treated with anti-VSV serum after one hour,
and serial dilutions plated onto chick embryo fibroblasts
monolayers for infectious center formation or samples were
placed in tissue culture for 24 hours and the culture SN
collected for PFU assay. Primary elutriated splenic B
cells were tested for support of VSV on the day of
isolation or were cultured with the indicated stimulus for
48 hours prior to infection.
infectious centers per 103 cells plated, mean of three
serial dilutions
PFU per 103 cells cultured, mean of two serial
dilutions
some clumping of cells, counts may be low
B cells cultured for 48 hours
--- -_
u_--
------- 
Table 2
Small elutriated B cells were cultured for 48
hours with the indicated stimulus prior to assay. Cells
were labeled for 2 hours with 35s-methionine , lysed , and
samples assayed for incorporation by TCA precipitation.
mean of duplicate determinations
TABLE 
ANALYSIS OF SUPPORT OF VSV INFECTION BY B CELL LINES
REPRESENTING DIFFERENT DIFFERENTIATION STATES
STAGE ff b
70Z/3 pre B 314 10, 000
BCL1 immature 102 5,400
Sp2/0 myeloma 297 000
36- hybridoma 353 000
i' ,
( f'
, I:
, i
, tI
, ::
PRIMARY S CELLS
unstimulated
unstimulated/cultu red
LPS activated 161 960
. '.
. i
:1:
TABLE 2
INCREASED PROTEIN SYNTHESIS OBSERVED WITH
CHANGES IN THE ACTIVATION STATE
facto crease
541
Splenic SN 677
Th1 SN 823
Th2 SN 253
ANTI- 606
ANTI- Ig + Sp SN 594 10X
ANTI- Ig + Th1 SN 231 10X
ANTI-Ig + Th2 SN 196 14X
LPS 114 477 25X
FIGURE 1
- - - -
STAGES OFB CELL ACTIVATION AND DIFFERENTIATION
AFFECTED BY STIMULATION WITH THE INDUCERS USED
IN THIS STUDY
ge otion: blastogenesis
cell cyc C? 
-- 
TIMUL
proliferation differentiation
antibody
Iymphokines
ANTI-
(Fab)'
ANTI-Ig + Iymphokines
(Fab)'
LPS
hokines
stage of action I L-
IFN-gamma
IL-2 IL-
IL- 5 IL-
IL-2 IL-
IL- 5 IL-
IFN-gamma
p!lne source:
defined Iymphokines present in SNs prepared from the indicated
cell source
CD 4+, Th (D1.6 SN): IL- , IL- , gamma- IFN , Iymphotoxin , GM-CSF
CD4+ , T (CDC35 SN): IL- , IL- , IL- , IL-6, Iymphotoxin , GM-CSF
polyclonal splenic SN: above Iymphokines except low levels of IL-
FIGURE 2
VESICULAR STOMATITIS VIRUS
r- r- X NS I I
- leader sequences, 50 
N - nucleocapsid, 1326 NT
NS- nucleocapsid associated, 815 NT
M - matrix , inner membrane , 813 
G - glycoprotein , spikes , 1665 
- RNA dependent RNA polymerase, 6500 NT
x - intergenic spaces, 2-4 NT
NEWCASTLE DISEASE VIRUS
I I
NP x P
I I
- leader sequence , 55 
NP - nucleocapsid, 1746 
P - nucleocapsid , 1451 
M - matrix , 1241 
Fo - fusion , 1792 
- hemagglutinin-neuraminidase , 2031 
L - RNA dependent RNA polymerase , 8704 NT
- intergenic spaces, 0-31 NT
MATERIALS AND METHODS
Mice CBA/NJ X A. By/J female or A. By/J X CBA/NJ
male and female mice were bred and maintained in our own
animal facilities and used between 12 and 24 weeks of age.
Parental stocks of CBA/NJ and A. By/J were obtained from
Jackson Laboratories , Bar Harbor, ME.
virus stocks: vesicular stomatitis virus , VSV
strain Salt Lake city, was obtained from Dr. T. Morrison
(univ. Mass. Med. School) and stocks were prepared in CHO
cells and purified as previously described (Chatis and
Morrison, 1981). Newcastle disease virus, NDV, strain
Australian Victoria, was obtained from Dr. R. Iorio (Univ.
Mass. Med. School) and stocks were prepared as described
(Hightower and Bratt, 1975).
B lvrphocvte preparation Spleen cell suspensions
were prepared by gently pressing spleens between glass
microscope slides, depleting debris by passage through
nylon mesh and red blood cells by treatment with Tris-
buffered NH4Cl (Mishell and Shiigi, 1980). Pooled spleen
cell suspensions were washed twice by centrifugation
through modi f ied Hank' s Balanced Sal t Solution (BSS)
supplemented with 1. 5% vol/vol fetal calf serum (BSS-FCS)
and enriched for B cells by complement mediated depletion
- - 
of T cells, i. e. cells were exposed to anti-Thy 1.
2 and
anti-Ly 2. 2 monoclonal antibodies for 1 hour on 
ice,
washed and treated for 1 hour at 370C with a 
1: 10 dilution
of rabbit complement (Pelfreeze, Rodgers, Ark.
) or guinea
pig complement (Rockland, Gilbertsville, pa.
) pre-adsorbed
on mouse splenocytes.
Cell Se aration: splenocytes enriched for B cells
were resuspended to 50 X 106/ml in BSS-FCS supplemented
with 125 ug/ml DNase I (sigma, st. Louis, Mo.
) and
incubated for 30 min. at 22 The B cell populatio
was
separated into small and large cell fractions by
counterflow centrifugal elutriation (model J-6B; Beckman
Instruments, Palo Alto, CA. ) as previously described
(Biron and Welsh, 1982). Cells eluting at a flow rate of
20 ml/min with a sYmetrical peak and a mean cell volume
of 120 um3 were collected and defined as the small resting
fraction (Tony et. al., 1985) (approximately 20% of input
cells) . This stringent size cut was used to ensure that
the starting population was in the resting state.
Spontaneous 3H-thymidine incorporation was not observed in
these small cell populations. Cell size was determined by
using a Coulter Channelyzer (coulter Electronics, Inc.,
Hialeah, FL. Cells eluting after a flow rate of 22
ml/min. was reached contained endogenously activated B
.. '" .
cells, macrophages, and polymorphonuclear monocytes.
B cell cultures: Small B cells were cultured in
complete media (CM): RPMI 1640 supplemented with 10%
fetal calf serum, 2mM L-glutamine, 100 units of
penicilli , 100 ug of streptomycin, 10 ug of gentimycin,
MEM non-essential amino acids per ml and 5 X 10-5 M 2-
mercaptoethanol. Cells were cultured with various
lymphokines and mi togens in 60 .mm tissue culture dishes, 5
ml/dish, at a cell concentration of 5 X 106
/ml, at 370C in
a 5% C02 in air mixture.
Cell proliferation in B cell cultures activated by
mitogens and/or lYmphokines was assayed by 3H-thYmidine
uptake. Cul tured B cells or hybridoma cells were
harvested, washed, and triplicate samples of 5 X 105
/200
ul of viable cells were placed into 96 well microtiter
trays with 1 uci/well of 3H-thymidine (NET-027, 6. 7ci/mM,
New England Nuclear) Plates were incubated at 37
C for 6
hour, harvested using a PHD cell harvester 
(cambridg
Technology Inc., Cambridge, Ma. ), and thYmidine
incorporation assessed by scintillation counting.
Mi toqens and LVIPhokines The B cell mitogen,
lipopolysaccharide (LPS W, E. coli 055: B5. Difco
Laboratories) was used at a final concentration of 50
ug/ml of culture medium. Rabbit anti-mouse F(ab) 1
antiserum (anti-Ig) was obtained from rabbits
hyperimmunized with F(ab) ' 2 fragments of monoclonal
antibody UPC10 (kappa, gamma 1). Anti-F (ab) ' 2 antibodies
were affinity purified from hyperimmune serum by
adsorption and acid elution from an immunoadsorbent of
normal mouse Ig coupled to Sepharose 4B. F ( ab ' ) 2
fragments of the rabbit antibody were prepared by
digestion with pepsin followed by chromatography on a
Sephadex G-100 column and used as a B cell mitogen at 10-
25 ug/ml. Lymphokine containing supernatants 
(SN) were
prepared from cloned lines of distinct T helper cell
subpopulations; Th1 - clone D1. 6 (Kurt-Jones et. al.,
1987); Th2 - clones CDC25 or CDC35 (Tony et.al., 1985)
generously provided by Dr. D. Parker
(Univ . Mass . Med. School) by induction for 24 hours with 4
ug/ml of Concanavalin A (Con A, sigma) a.t a cell
concentration of 106/ml. Lymphokine containing S was
also prepared by incubating total spleen cells from A. By/J
- -
or A/J mice at a cell concentration of 107/ml with 4 ug/ml
Con A for 24 hours. Con A was removed from all SNs by,
passage over a methyl-alpha-D-mannopyranoside sepharose
column. All SN were- used at a 50% concentration in
cultures supplemented with methyl alpha-d-mannopyranoside
at 10 mg/ml.
- -
Antibodies and Cell Lines: The following
monoclonal antibodies were used in depletion experiments:
anti-Thy 1. 2 (ATCC # TIB 99) (Marshak-Rothstei et. ale ,
1979), anti-Ly 2. (ATCC# TIB 150), anti-B220 (14.
(Kincad et. al., 1981) and RA3. 3A1 (Coffman and Weissman,
1981)), anti-Iak (14. 4S, (Ozato et. al. , 1980), 10. 16,
ATCC# TIB 93; and 11. 2, ATCC# TIB 94), anti-B cell
(J11D, (Bruce et. al., 1981)), anti-rat kappa (Mar 18.
ATCC# TIB 216). The pre B cell line 70Z/3 (ATCC# TIB 158)
and the immature B cell line BCL1 (ATCC# TIB 197) were
used as target cells for VSV. Also the B cell hybridoma
fusion partner Sp2/0 (ATCC# CRL 1581) or the antibody
secreting hybridoma, 36-65 (Marshak-Rothstein et. ale ,
1980) were found to be permissive for virus infection and
were used as control susceptible B cell target lines in
all experiments. Rabbit anti-VSV serum, supplied by Dr.
T. Morrison, or rabbit anti-NDV serum, supplied by Dr. R.
Iorio, were used to neutralize virus. Monoclonal antibody
HN 2b against the NDV hemagglutinin-neuraminidase protein
was provided by Dr. R. Iorio.
Assa s for Virus Infection: B cells, usually 5 x
106 cells cultured for various times under various
activation conditions., were infected with VSV at a
multiplicity of infection (m. ) of 10 PFU/cell for 1
hour at 370C. Cells were washed twice with CM and
resuspended in CM with sufficient rabbit anti-VSV serum to
neutralize all input virus. After 30 mins. at 37
C cells
were washed twice, resuspended to the original volume, and
counted. Samples were also taken for an overnight culture
to be used in an infectious center assay for determining
virus production, and for 35S-methionine labeling of viral
and host proteins.
The number of infected cells was determined using
an infectious center assay. Briefly, duplicate 0. 2 ml
aliquots from samples of serially diluted cells were
plated onto 60 mm tissue culture dishes of 20 chick embryo
fibroblast monolayers. Cell samples were plated in a 1: 1
mix of CM containing cells and overlay media (MEM with
5% serum, penicillin, streptomycin, gentimycin, tryptose
phosphate broth, caCl2, 0. 8% agarose (Seaplaque , FMC
biochemicals), and 0. 2% agar (Bacto-agar, Difco)). After
1 hour the monolayers were overlayed with an additional 5
ml of overlay media. virus plaques were counted at 24 and
48 hours.
virus production (PFU) was assayed 24 hours after
infection by incubating 5 X 105 infected cells in 1 ml of
CM overnight in 24 well tissue culture dishes. SN were
collected and infectious virus was titrated on 2 chick
embryo fibroblast monolayers. To examine the effect of
trypsin on NDV plaque production, monolayers of 20 chick
embryo cells were washed with phosphate buffered saline
prio to addition of serially diluted SN and overlayed
with avirulent media (Media 99 with penicillin,
streptomycin, gentimycin, tryptose phosphate broth,
bicarbonate, 10 ug/ml trypsin, 0. 4% agarose, and 0.
agar) .
In some experiments small B cells were pre infected
with VSV at a m. i. of 10 for 2 hrs. at 370C, washed, and
excess virus neutralized before activation in culture.
After 24 or 48 hours in culture these preinfected cells
were washed and excess virus was again neutralized before
analyzing these cells for infectious center formation and
virus production.
viral protein synthesis was examined by continuous
labeling with 35s-methionine for 2 hours of cells infected
8-10 hours previously. Briefly, cells were washed twice in
CM made with methionine free RPMI 1640, resuspended at 10
x 106/ml with 50uci of 35s-methionine (Amersham #SJ-1515,
1250 Ci/mM specific activity, Amersham Corp., Arlington
Heights, IL. ) and pulsed for 2 hours at 370C. Thirty min.
prior to cell lysis, iodoacetamide in PBS (Sigma,
St. Louis , Mo. ) was added to a final concentration of 7-10
ro. Cells were spun down, SN removed, and cell pellets
lysed with lysing buffer (0. 5% NP-40 , 0. 5% deoxycholate
50 mm Tris, pH 8. 0) with phenylmethylsulfonyl fluoride
(final concentration 2 ro). Cell lysates were microfuged
and the SN were ana lysed on a 10% SDS acrylamide gel with
fluorography.
Immunoprecipitation of viral proteins was carried
out by adding protein A-sepharose 4B beads (Sigma , st.
Louis, Mo. ), previously loaded with rabbit anti-VSV or
anti-NDV antibodies for 2 hrs at R. T. and then washed with
5% NP-40 in 50mm Tris pH 8. 0, to cell lysates or 
virto translation products. Samples were incubated for 2
hrs. at R. T., washed 4 times with 0. 5% NP-40, 400mm NaCl
in 50mm Tris pH 8. 0, and radiolabelled proteins were
eluted by boiling in SDS gel sample buffer for 5 mins. and
electrophoresed on a 10% SDS acrylamide gel.
RNA extraction and Northern analysis RNA was
extracted from infected B cell populations by the acid
phenol extraction method (Chomczynski and Sacchi, 1987).
Briefly, cell pellets were dissolved in solution D (4M
guanidinium thiocyanate , 25ro sodium citrate pH 7 , 0.
sarcosyl , O. lM 2-mercactoethanol, 100ul/ 106 cells).
sodium acetate pH 4. 0 (10ul/ 106 cells), phenol (water
saturated , 100ul/ 106 cells), and chloroform/isoamyl
alcolol (49:1 , 20ul/ 106 cells) were sequentially added to
the lysates , mixed after each addition with a final vortex
of 10 seconds and placed on ice for 15 mins.
preparations were spun at 9 000 rpm for 20 mins at 40C,
upper phases were re extracted with phenol
/chloroform: isoamyl alcohol twice, after a final spin the
upper phase was removed and solution D (15ulj 106 cells)
was added. One volume of cold isopropanol was added, and
RNA was precipitated for at least 1 hour at -2 OoC. The
RNA pellet was microfuged (40C for 20 mins. ), washed with
70% ethanol and dried. Concentrations were determined by
optical density after dissolving in sterile distilled
wa ter .
RNA was analyzed by Northern blotting. Total RNA
was separated on a 1% formaldehyde-agarose gel (Maniatis
1982) run at 24 volts for 16-20 hours and transfered to
Zetabind (CUNO, Inc. , Meriden , ct. ) by capillary elution
with lOX SSC buffer (Maniatis , 1982) for greater than 20
hours. After transfer, the filter was washed in 2X SSC
baked in vacuum oven at 800 C for 2 hours , washed in 1%
SDS , O. lX SSC at 650 C for 1 hour, and pre-hybridized at
420 C overnight in 50% deionized formamide , IX Denhardts
(Maniatis , 1982), 1% SDS , 5X SSC, 10mM EDTA , 50mM NaP04 pH
, 0. 2 mgjml yeast tRNA , 0. 2 mgjml denatured salmon
- - - -
sperm DNA, and 8. 2% H20.
Plasmid and robe aration: Plasmids
containing complete cDNA sequences for the VSV G (Rose and
Bergman, 1982), M (Rose and Gallione, 1981), N (Sprague
et. al., 1983), and NS (Gallione et.al., 1981) were
obtained from Dr. John K. Rose. A plasmid encoding the
VSV L gene was obtained from Dr. Manfred Schubert
(schubert et. al., 1985). These plasmids were used to
transform E. coli (strain DHfr alpha) and prepared by
standard techniques (Maniatis, 1982). Inserts were
prepared by digesting the plasmids with appropriate
restriction enzymes and purified from agarose gel using
the gene clean system (BIO 101 Inc., La Jolla, CA.
Probes were labeled using the random primer labeling
procedure (Feinberg and vogelstein, 1983): 1 ul of DNA (25
ngjul) was added to 8 ul of sterile double distilled H20
and denatured by heating to 95-100 C for 3 mins., and
iced. After cooling 2 ul dNTP6-10X pol buffer (pd (N) 6
(Pharmacia, 135 ugjml), pol buffer (70ro Tris pH 7. 4, 70
ro MgCl2, 0. 5 M NaCl)), 1 ul 0. 5 ro dC (dTTP, cATP
dGTP), 8 ul 32p-dCTP (3000 Ci/ro), and 2-3 units Klenow
fragment of DNA polymerase were added. This mixture was
incubated 30 mins. at 370C , and unincorporated nucleotides
were removed by passage over a G-50 sephadex spin column.
The preparation was added to hybridization buffer (same as
pre-hybridizati ), boiled 10 mins., and immediately added
to filter which was hybridized overnight at 420C. The
filter was rinsed in 2X SSC, 0. 1% SDS for 5 mins. at R. T.,
washed twice with O. IX SSC, 0. 1% SDS for 45 mins. at 50
prior to exposure to film at -700C with developing
screens.
In vitro translation: Translation reactions were
carried out in a wheat germ system according to described
methods (Erickson and Blobel, 1983). Briefly, 25 ul
reactions containing 1 ug of total B cell RNA, 30%
(vol/vol) nuclease treated wheat germ extract, and 18.
uci 35S-methionine were incubated 90 mins. at 240C prior
to product analysis by SDS gel electrophoresis. Wheat
germ extract was supplemented with 25 ro creatine
phosphate, 1. 8 ro ATP , 0. 3 ro GTP, 0. 18 ro of each amino
acid excluding methionine, 25 ro HEPES (pH 7. 8), 64 ug/ml
creatine phosphokinase , 250 uM spermidine, 3. 2 ro DTT,
0016% Nikkol, 7U/25ul RNase inhibitor, 0. 9 ro MgOAc, and
20 ro KOAc.
. c;
CHAPTER 1
VIRUS-LYMPHOCYTE INTERACTIONS: INDUCTIVE SIGNALS
NECESSARY TO RENDER B LYMPHOCYTES SUSCEPTIBLE TO
VESICULA STOMATITIS VIRUS INFECTION
This manuscript was published in the Journal of virology,
July 1990 , Vol. 64, p. 3289-3296.
Material and methods and references have been incorporated
into the appropriate sections of the thesis. Tables and
figures have been renumbered.
ABSTRACT
We have examined the inductive signals necessary
to render B lYmphocytes capable of supporting a productive
Vesicular stomatitis virus infection. Small murine
splenic B cells, in the Go phase of the cell cycle, were
cultured with stimulators which allow progression through
various stages in the activation/ differentiation pathway
leading to antibody secretion. We find that VSV
expression is dependent on the state of B cell activation
and that three distinct phases can be defined. A non-
supportive state, which is defined by the failure to
produce infectious centers, viral proteins, or PFUs, is
characteristic of freshly isolated small B cells, B cells
cultured 48 hours without further stimulation, or B cells
in the G1 phase of the cell cycle induced by culture with
T cell derived lymphokines. This refractory state was not
due to a failure of virus uptake. Activation of Go B
cells with anti-immunoglobulin, at doses which allow entry
into S phase, rendered them capable of synthesizing viral
proteins and increased the number of B cells producing
infectious centers , without enhancing PFU production on a
per cell basis. In contrast , B cells stimulated with
multiple inductive signals provided by anti- immunoglobulin
and lymphokines showed increased infectious particle
producti (7 PFU/infectious center). Lipopolysacchar ide
stimulation , acting through another induction pathway,
caused the maximum increase in the number of infected B
cells and infectious particle production (25
PFU/infectious center).
INTRODUCTION
The alarming increase in virus mediated
immunodeficiency disease has focused attention on the
interactions between viruses and the immune system, under
conditions where lYmphocytes and monocytes serve as
targets for virus infection. Potential restrictions on
these interactions can be imposed by unique features of
the virus and/or intrinsic properties of the target cell
that may alter susceptibil i ty . As host cells, lYmphocytes
can present significant impediments to virus infection.
The availability of receptors for virus binding
and entry is the first potential level of restriction.
The necessary receptor may be conf ined to a lineage, to a
subpopulation within a lineage, or to cells in a
particular activation state. For example, B lYmphocytes
are the primary target of Epstein Barr virus , because they
are the principle cell population that expresses the CR2
(CD21) surface antigen which is used as a receptor for
virus entry (Coffman and Weissman, 1981; Cooper et. al.,
1988) . B cells stimulated to enter the S phase of the
cell cycle lose their susceptibility to EBV because of the
downregulation of the CR2 molecule from the cell surface
(casali and Notkins , 1989; Crawford and Ando, 1986; Tovey
et. al., 1978).
The necessity to induce critical biosynthetic
pathways in the target cell provide a second level of
restriction for virus infection, since most viruses are
dependent for their replication on cellular factors that
may be limited to cells in a pa ticular activation state
or expressed only in cells in a particular state of
differentiation. Normally, T and B lYmphocytes, both
sessile and recirculating, are in the metabolically
quiescent, (G ) resting phase of the cell cycle; in this
state the cells have little cytoplasmic volume (Phillips
and Parker, 1984), minimal biosynthetic capability (Howard
et. al. , 1982; Paul, 1989), and are poor hosts for viral
infection (Bloom et. al., 1976; Jimenez et. al., 1971;
Olding et. al., 1975). Upon activation lymphocytes become
more biosynthetically capable of supporting the synthesis
of viral proteins and nucleic acids, as illustrated by the
finding that mitogenically stimulated lymphocytes will
support a virus infection that resting B and T cells
cannot (Bloom et. al., 1976; Edelman and Wheelock , 1966;
McChesney and Oldstone, 1987; Wheelock and Toy, 1973).
Although the requirement for "activation" is well
known, the actual activation requirements for a productive
infection are not. For B cells, the process of activation
is complex; mitogens , specific antigen , lYmphokines, or
polyclonal activators such as anti- immunoglobulin
al though acting through different pathways (DeFranco
1987) are each capable of driving, to various extents,
resting B cells through the differentiation pathway
towards antibody secretion. Thus, exposure to different
inductive stimuli provides the opportunity to correlate
the ability of a B cell to support a productive virus
infection with the distinct cellular changes induced by an
activating agent.
We are interested in determining the spectrum of
inductive signals that render B lymphocytes susceptible to
virus infection. This analysis is facilitated by the
ability to prepare a homogeneous starting population of
resting small B cells, in the Go phase of the cell cycle,
for analysis. Activation of a small B cell results in
dramatic increase in the biochemical activity of the cell
with a concurrent increase in cell size and decrease in
cell density (DeFranco, 1987; Paul, 1989). The physical
changes in activated B cells allows for the fractionation
of freshly isolated cell populations into small " resting"
or la.rge "activated" B cells by bouyant density and
sedimentation velocity centrifugation. We determined how
the process of infection is affected by the activation
process by assessing susceptibility to virus infection in
resting B cell populations exposed to defined activation
inducers that were chosen based on their following
properti ties: (1) Exposure of small resting B cells to
anti-Ig plus lymphokines derived from T helper cells or to
the mitogen LPS allows full activation causing both
proliferation and differentiation to antibody secreting
cells (Howard et. al., 1982; Parker et. al. , 1980); (2)
Incubation with anti-Ig, causes small resting Go B cells
to enter S phase without further differentiation
(DeFranco, 1987); and (3) Lymphokines , in particular IL-4,
support B cell transit into the G1 phase of the cell cycle
(O'Garra et. al. , 1988; Paul, 1989).
We have analyzed changes in B cell susceptibility
to infection using Vesicular stomatitis virus. vsv is a
negative-stranded RNA virus in the Rhabdovirus family.
Replication occurs in the cytoplasm of the infected cell
and is dependent upon host cell factors (Emerson , 1985;
Wheelock and Toy, 1973). We followed the process of
infection experimentally in B cell populations by:
using SDS gel electrophoresis of 35s-methionine labelled
cell lysates to ascertain viral protein synthesis, 2) the
number of infected cells in the population is determined
by an infectious center formation, and 3) titering
supernatants of infected cultures for the production of
infectious virus particles
We find striking differences in the ability of B
cells to support viral protein synthesis and/or production
of infectious virus particles which are dependent on the
activation state induced. These effects are not due to a
restriction on virus entry.
Resul ts
vsv infection in B cell enriched s leen cell ulations.
The ability of murine spleen cell populations
enriched for B cells to support VSV infection and
replication after activation with various stimuli was
determined. The B cells used for these experiments were
freshly isolated and unelutriated and represented a
continuum of activation states due to in vivo exposure to
environmental antigens. Cells so prepared are enriched
for B cells as indicated by the 95% fluorescent staining
for surface Ig (J. Riggs , personal communication). Table
3, Expt. 1 shows the number of infectious centers/103
plated cells exposed to different culture conditions for
48 hours. B cells cultured for 48 hrs. with no additional
stimulus produce 39 infectious centers per 103 cells
considered here as the unacti vated background response.
Cells cultured with splenic SN factors, which support
transition to the G1 phase of the cell cycle, produced a
modest increase in infectious centers , while B cells which
received inductive signals from anti-Ig, which allows
transit to S , produced 200 infectious centers. Cells
which were exposed to more rigorous stimulation with anti-
Ig plus splenic SN or LPS produced more infectious
centers , 340/103 and 300/103 , respectively. Thus , up to
30% of the cells activated with anti-Ig plus SN or LPS can
support virus infection which is comparable by this assay
to that observed in the permissive cell lines CHO (21%)
and SP2/0 (34%). Expt. 2 and others not shown yield
similar results.
These data also imply that B cells are the target
for VSV infection , given that 95% of the starting cell
population is sIg , and the specificity of B cell
induction with anti-Ig and LPS activators. Moreover,
because not all B cells are activated to proliferation by
LPS or anti-Ig (30 and 60% respectively; Ashman , 1984;
DeFranco et. al. , 1982), these results also suggest that a
very high proportion of activated cells are infected.
small resting B cells can be activated to support vsv.
Although establishing the target population , the
previous experiments could not define the minimum
activation signal (s) required for virus infection because
of the heterogeneous nature of the B cells in the starting
population. Accordingly, subsequent assessments of the
role of activation employed freshly isolated elutriated
small B cells. This population was unable to support
virus infection following exposure to VSV as assessed by
infectious center assay (4/103 plated cells) or virus
production (Table 4, Expt. 1). MoreQver, B cells
maintained in culture for 48 hours without stimulation
also showed no increase in number of infectious centers
(3/103 plated cells), thus demonstrating that no inducers
are found in culture medium. This small number of
infectious centers produced by freshly isolated or
cultured but unstimulated small B cells is in striking
contrast to that found for the unstimulated total B cell
enriched population (Table 3). This change is likely the
result of the removal of endogenously activated B cells or
other VSV supportive cells from the elutriated small B
----
cell population.
Infectious center formation markedly increased in
small B cells exposed to B cell activators. In this
regard, LPS activation was the most effective , at 48 hours
there was a 65 fold increase over the small B cell
background to 195 infectious centers per 103 cells plated;
exposure to anti-Ig with or without suplementation with
lymphokines caused 20 to 30 fold increases , respectively.
The most striking change brought about by
variation in activation stimulus was in infectious
particle production. B cells stimulated with anti-Ig had
increased numbers of infectious centers , 90/103 cells
plated, and increased PFU produced , 52/103 cells cultured
but the virus yield on a per cell basis was less than 1
PFU/ infectious center, which is comparable to that seen in
unstimulated B cell cultures. In contrast, anti-Ig plus
SN increased PFU formation 200 fold overall
, and also
increased virus production on a per cell basis to 7
PFU / infectious center. LPS stimulated B cell cultures
were most efficient in PFU production which increased
000 fold over the small B cell background to 25
PFU/infectious center
, a value close to the level of virus
production seen in permissive cell lines. In other
experiments B cells were cultured with anti-Ig and SN from
Th2 T cell clones (Table 4, Expt. 2). While these SN
contain a more restricted array of growth promoting
lymphokines than splenic SN (27), virus production was
comparable to that observed in anti-Ig plus splenic SN
cul tures . These data demonstrate that both the number of
cells infected and the level of PFU production are
effected by the activation stimuli.
The progress of infection was also monitered by
examining viral protein synthesis. As expected VSV
proteins are readily seen in productively infected B cells
stimulated by anti-Ig and SN or LPS (Figure 3, lanes 4 and
8) . VSV protein synthesis is also seen in cells
stimulated with anti-Ig despite the fact that low numbers
of infectious particles were produced (F ig. 3, lane 2).
Immunoprecipitation shows that the lack of PFU production
in anti-Ig treated B cells is not readily correlated to
qualitative differences in the array of viral proteins
synthesized.
The high proportion of B cells in the starting
population combined with the specificity of the inducers
for B cells and the high number of infected cells in the
cultures is consistent with the notion that B cells are
the target of virus infection in this system. This
position is directly supported by experiments where B cell
specifi monoclonal antibodies were used with complement
to deplete VSV infected B cell populations previously
activated with anti-Ig and SN. Treatment with anti-B220,
anti-Ia, and J11D resulted in a decrease in cell numbers
of 37%, 88%, and 78% of cultured cells with a
corresponding decrease in infectious centers of 
44%, 86%,
and 65% , respectively. PFU production also decreased
(data not shown). These data demonstrate , by a number of
criteria, that B cells are the target population and
activation renders them susceptible to infection.
Multiple siqnals are required for a productive infection.
All B cell inductive regimens employed in previous
experiments allowed progression of the B cells into the
initial s phase of the cell cycle as indicated by the
incorporation of 3H-thYmidine (Fig. 4, stimuli 5-9). Yet
the data for anti-Ig stimulated cells shows that entry
into s is not sufficient .for a productive VSV infection.
However, B cells cultured with anti-Ig- and lYmphokines did
show PFU production, suggesting that either additional
differentiation steps supported by lYmphokines are
necessary for virus production, or that lYmphokines can
directly activate B cells to a permissive state without
other inductive signals. Ipdeed, lymphokines facilitate
the Go to G1 cell cycle transit in small B cells causing
increases in B cell volume, RNA synthesis , and protein
synthesis (O'Garra et. al., 1988; Snapper et. al. , 1988)
which may be sufficient to support virus infection.
examine this possibility, we cultured small B cells with
lymphokine containing SN and determined their subsequent
susceptibility to VSV infection. Lymphokines were derived
from SN of Con A activated splenic T cells or from T
helper cell clones. T helper cell clones represent two
distinct T helper subpopulations (Th1 and Th2) (27). Th1
cells secrete IL-2 and gamma-interferon, while Th2 cells
secrete IL-4, IL-5, and IL-6 as their unique lymphokines
whereas both secrete IL-3 , lymphotoxin, GM-CSF. Small B
cells exposed to these SNs for 48 hours produced no
infectious centers, PFUs (Table 5) or viral proteins (fig
, lane 7, splenic SN). The SNs. did induce the expected
increase in B cell size (fig. 5) and protein synthesis
indicated by a 10-fold increase in 35S-methionine
incorporated into TCA precipitable material, (data not
shown) . Thus, lymphokine exposure alone is not sufficient
to render B cells capable of supporting VSV infection,
suggesting the requirement for mul tiple activation
signals.
vsv entr into restin B cells.
Our previous findings showed that freshly
isolated, unstimulated but cultured, or lymphokine treated
B cells were incapable of supporting VSV infection as
assessed by our criteria for infection. since this could
suggest that activation was necessary for virus entry, we
next determined if non-permissive B cells were blocked at
this level. Initial experiments using 35S labeled virions
to examine vsv particle uptake by freshly isolated or
unstimulated cultured small resting B cells indicated no
apparent block at either binding or internalization when
compared to control populations (data not shown). Based
upon these studies, we used a second approach which
assumed that small B cells exposed to VSV could be made to
express virus when activated to a permissive state. This
also assumes that the input virus is not degraded in the
cell before activation. Accordingly, small resting B
cells were incubated with VSV and excess virus
neutralized. Cells so treated were cultured without
stimulation, or were exposed to splenic SN, or LPS for 24
and 48 hours. A representative expt. using this approach
is shown in Table 6, part At 24 hours there is no
significant increase in infectious foci in any population
which demonstrates the requirement for B cell activation
for virus expression. By 48 hours there is a marked
increase in the number of infectious centers in the LPS
stimulated cultures , 122/103 plated cells , as well as PFU
producti , 1 700/103 cells cultured, which are comparable
values to those obtained when B cells are activated with
LPS before VSV exposure (Table 6, part 2). In contrast,
unstimulated B cells or B cells exposed to lYmphokines
remain non-permissive. Thus, the ability of B cells to
support VSV infection is dependent upon cellular changes
associated with B cell activation and is not due to a
failure in virus uptake.
Discussion
The experiments presented here define at least
three distinct phases during B cell activation that
support VSV infection to various extents and suggest that
- optimum virus production is critically dependent on host-
derived maturation factor (s) produced in B cells
undergoing the activation process.
Our finding that murine B cells can be
productively infected by VSV is in contrast to the work of
other investigators (Bloom et. al., 1970; Bloom et. al.,
1976; Kano et. al. , 1973; Webb et. al., 1981) who have
previously reported that spleen B cell populations,
partially purified by different techniques , exposed to LPS
remain refractory to infection. That B cells are the
maj or targets of VSV in our system is demonstrated by a
numer of lines of evidence. First and foremost is the
relative purity of our target cell population which is
greater than 95% surface immunoglobulin positive.
Further, purification of small B cells by counter-current
elutriation, and the use of LPS or anti-Ig served to
selectively activate only B cells in the starting
population. Moreover , culture of the starting small B
lymphocyte population with lymphokines in the absence of
anti-Ig fails to induce cells capable of supporting viral
protein synthesis or infectious virus particle production
thus excluding the possibility that a quiescent
contaminating cell population is enriched or activated by
lymphokine exposure. We also find that B cell specific
monoclonal antibodies in the presence of complement, can
specifically deplete, up to 88%, of the cells giving rise
- .
to infectious foci and to infectious particles in VSV-
infected B cell populations activated in culture with
anti-Ig and T cell-derived lymphokines.
Virus infection in activated B cells is efficient.
In B cell populations cultured with LPS or anti-Ig and
lymphokines the relative proportion of susceptible cells
as moni tered by infectious center formation, is comparable
to the fraction of B cells known to be stimulated to
proliferation under the conditions used in these
experiments (Ashman , 1984; DeFranco et. al. , 1982).
Moreover, virus production , as monitored by infectious
particle titer, is similar to that found when conventional
VSv-susceptible target populations, such as CHO cells , are
analyzed.
Activation is clearly necessary to render B cells
susceptible to infection , as small resting B cells in the
Go stage of the cell cycle are refractory to vsv. This
refractory state is not due to the absence of a critical
receptor necessary for virus entry. We have shown that
small lymphocytes , previously exposed to VSV, will go on
to produce infectious foci and infectious virus particles
upon subsequent exposure to LPS. Thus, a small B cell can
take up virus, but reqires activation to support the
process of infection.
What cellular changes constitute a supportive
state? Exposure to lymphokines from cloned Th1 or Th2
cells or polyclonally activated splenic T cells , which
cause transit from Go to G1 and B cell enlargement (Fig.
4), was not sufficient to render B cells capable of
supporting VSV or even the production of virus proteins.
Because preliminary experiments indicate that these cells
produce all VSV mRAs , the block is not at the level of
primary viral transcription (M. R. Schmidt, K. A. Gravel
and R. T. Woodland, Abstr. , ICN-UCI Int. Conf. on Virol.,
1990) . We are currently trying to determine if lymphokine
exposure is neutral or renders the cell anergic to
inductive stimuli that would normally support a productive
virus infection.
Small B cells cultured with mitogenic doses of
anti-Ig produced viral proteins and showed a 3D-fold
increase in infectious centers over background, but failed
to produce infectious virus particles at a high rate (less
than one per infectious center). This apparent disparity
between the number of infectious centers and PFUs detected
in SNs may be owing to the potential for readsorption of
released virus particles by B cells in liquid culture.
contrast, virus production as assayed by focus formation
would be expected to be more unambiguous because of direct
contact of an infected B cell with the susceptible
monolayer. Anti-Ig stimulated B cells have some
characteristics of persistently infected cells which also
produce no or low levels of infectious particles. The
restriction on infectious particle production in anti-Ig
treated small B cells are similar to restrictions seen for
high rate immunoglobulin synthesis and secretion, as
exposure to lymphokines is necessary to facilitate both
processes. Thus, neither lymphokines nor anti-Ig alone
was sufficient to render B cells capable of high level
infectious particle production.
Activation of B cells with anti-Ig plus
lymphokines results in a fully permissive cell population
with a 10-fold increase in infectious virus particle
production per infectious center over that seen with B
cells treated with anti-Ig alone. These results are
consistent with a requirement for at least two inductive
signals to render B cells supportive of VSV production.
Anti-Ig mediates receptor crosslinking and internal
signalling followed by the induction of ew lYmphokine
receptors which allow subsequent differentiation events
supported by 1 Ymphokine ( s) present in the T cell derived
, and leads to increased virus production. One aspect of
these results is paradoxical, the Con A activated spleen
cell SNs used as one source of lYmphokines contain gamma-
interferon at levels sufficient to inhibit VSV production
by infected L cells (R. Welsh, personal communication).
This may suggest that gamma-interferon which facilitates
the maturation of activated B cells and the expression of
the IgG2a immunoglobulin isotype (Paul, 1989) has minimal
anti-viral activity on the B cells activated with anti-Ig.
It has been reported that gamma-interferon acts as a
growth factor rather than an anti-viral factor for
activated T cells (Landolfo et. al., 1988). Al ternati vely 
our finding that SN prepared from Th2 clones , which
secrete nd gamma-interferon, facilitates VSV production in
anti-Ig treated B cells as well as but no better than
spleen cell SN (Table 4) may suggest that the response to
enchancing" lYmphokine(s) in splenic SN can counteract
potentially suppressive effects due to interferon or other
cytokines . In this regard, it is noteworthy that IL-4 and
gamma-interferon have antagonistic effects on
immunoglobulin isotype expression (0' Garra et. al., 1988).
LPS is the most effective inductive regimen for
activating B cells to support VSV. Infectious virus
production per cell is comparable to that seen with
permissive" cell lines , such as CHO and SP2/0 (Table 
and 3-fold over that seen in anti-Ig plus lYmphokine
treated cultures. Although different - pathways of
activation are utilized by these two classes of activators
(DeFranco , 1987), both activation sequences result in
differentiation to antibody production, suggesting that
subsequent cellular changes during B cell activation
ultimately determine the level of PFU production. LPS
52 
activated B cells also show another property, preliminary
experiments indicate that exposure to spleen cell, Th1, or
Th2 derived lymphokines during LPS activation suppresses
VSV PFUs to background levels (M. R. Schmidt , K. A.
Gravel, and R. T. Woodland, Abstr., Annu. Meet. Am. Soc.
Virol., 1990), thus demonstrating a completely different
response pattern to the same collection of lYmphokines
from that of B cells activated with anti-Ig. This
reinforces the notion of enhancing and suppressive
lymphokines in the same SN and suggests to us a number of
possible models to explain the behavior of B cells exposed
to these lYmphokines. B cells reactive to LPS or anti-Ig
may represent stable and distinct B cell subpopulations
(Ashman, 1984; Flahart and Lawton , 1987) which differ in
the lymphokines to which they respond, or respond
differently to the same lYmphokines. Alternatively, LPS
and anti-Ig may both act on a single B cell population,
but each inducer, acting through a distinct activation
pathway, c uses a different array of lYmphokine receptors
to be expressed or modifies the B cell' s potential to
respond to the same collection of lymphokines. Addi tional
studies are in progress to distinguish amongst these
possibilities.
Restrictions on VSV expression in transformed
lymphoblastoid cell lines have been reported previously
(creager et. al., 1981; Creager et. al., 1982; Nowakowski
et. al., 1973a; Nowakowski et. al. , 1978b; Weck and Wagner
1978). However, it is not always possible to determine
how the process of transformation may have altered the
course of virus expression as it would have occured in
normal cells at equivalent stages of differentiation or
activation. In this report, we describe a system to
correlate the biochemical changes occuring during the
activation of normal B cells with the ability to support a
productive virus infection. In addition , as many
lymphokines have been cloned and are available as
recombinant molecules, this system permits another level
of analysis of the cellular changes induced by individual
lymphokines or combinations of lymphokines acting in
concert with other stimulators, which may not have been
detected by previous methods.
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Table and Fi ure le ends
Table 3
B cell enriched splenocyte populations were cultured
with the indicated stimuli for 48 hours before virus
infection.
Mean of duplicate determinations over three serial
dilutions. Values in parentheses are percentages of the
control values determined by using permissive cell lines.
In experiment 1, SP2/0 gave 344 infectious centers per 103
cells plated; in experiment 2 , CHO cells gave 210
infectious centers per 103 cells plated.
, Not done.
Table 4
Elutriated small B cell populations were cultured with
the indicated stimulus for 48 hours before virus
infection. Experiments 1 and 2 used different starting
populations. As a positive control, . 3 6-65 hybridoma
freshly isolated from culture , gave 339 infectious centers
per 103 cells and 1. 9 X 104 PFU/103 cultured cells in
experiment 1 and 1. 4 X 104 PFU/103 cultured cells in
experiment 2.
Mean of duplicate derterminations averaged over three
serial dilutions. ND, Not done.
Number of infectious particles per infectious center
(IC) .
Elutriated small B cells exposed to VSV on the day of
isolation.
Table 5
Elutriated small B cells were cultured with the
indicated stimulus for 48 hours before virus infection.
Mean of duplicated determinations averaged over three
serial dilutions.
Number of infectious particles per infectious center
(IC) .
Cells cultured for 48 hours without additions.
Table 6
In expt. 1, small B cells were infected on the day of
isolation and then cultured for 24 or 48 hours with the
indicated stimulus before assay. In expt. 2, another
sample from the same population of small B cells was
cultured for 48 hours with the indicated stimulus prior to
VSV infection.
Mean of duplicate determinations averaged over two
serial dilutions.
Number of infectious particles per infectious center.
ure 3
Immunoprecipitation of cell lysates with rabbit
anti-VSV serum from uninfected (lanes 1, 3, and 5) and
infected (lanes 2, 7, and 8) cells treated with anti-Ig
(lanes 1 and 2), anti-Ig and splenic SN (lanes 3 and 4),
SP2/0 cell line (lanes 5 and 6), splenic SN (lane 7), and
LPS (lane 8). At right are position markers for the
following viral proteins: RNA polYmerase (L), glycoprotein
(G), nucleocapsid-nonstructural proteins (N/NS), and
membrane protein (M).
F i ure 4
(3H) thYmidine incorporation in cultured B cell
populations. Treatment: Bar 1, unstimulated; bars 2 to 9
stimulation with splenic SN (2), Th (D1. 6) (3); Th2 SN
(CDC 35) (4), anti-Ig (5), anti-Ig and splenic SN (6),
andti-Ig and Th1 SN (7), anti-Ig and Th2 SN (8), and LPS
(9) .
ure 5
Cell volume profiles of elutriated B cell
populations. Shown are results for freshly isolated small
B cells (--) or populations cultured for 48 hours
unstimulated (.... ) or stimulated with splenic SN (- 
. -
Th1 SN (D1. 6) (- -), or Th2 SN (CDC 35) (- 
.. -
TABLE 3
B CELL ENRICHED SPLEEN POPULATIONS
ARE TARGETS FOR VSV INFECTION
INFECTIOUS CENTERS a
STIMULUS b
pt. pt.
39 (11)
SpSN 90 (26) 45 (21)
ANTI- 200 (58) 208 (99)
ANTI- Ig + SN 340 (98) 277 (131)
LPS 300 (87) 165 (78)
" !
TABLE 4
ACTIVATION OF SMALL RESTING B CELLS
TO SUPPORT VSV INFECTION
INFECTIOUS CENTERS b PRJ PFU/I.C.
pt. 1
c:1
NONE (cultured) c:1
ANTI- c:1
ANTI- Ig + Sp SN 450
LPS 195 300
t. 2
ANTI-
ANTI-Ig + Th2 SN 395
LPS 050
TABLE 5
INABILITY OF SMALL B CELLS STIMULATED
WITH L YMPHOKINE-RICH SN TO SUPPORT
VSV INFECTION
TIMULUS a INFECTIOU ENTER PFU
t- 
Splenic SN
Th1 SN (01.
Th2 SN (CDC 35)
ANTI- 110
LPS 330 560
TABLE 6
INFECTIOUS CENTER FORMATION AND VIRUS PRODUCTION
IN SMALL RESTING B CELLS FOLLOWING VSV EXPOSURE
AND IN VITRO CULTURE
STIMULUS a INFECTIOUS CENTERS b PFU PFU/I.C.
t. 1
4 hr
Splenic SN
LPS 122 700
t. 2
Splenic SN
LPS 152 815 
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CHAPTER 2
Lymphokine effects on VSV non-supportive and supportive
B cell populations
INTRODUCTION
LYmphokines are powerful regulators of B cell
function. The requirement of B cells for extraneous
factors to facilitate antibody secretion, proliferation
and isotype switching has been used to define the function
of particular lymphokines and has provided a model to
study the molecular basis of lymphokine action. For
example, B cells activated with LPS when co-cultured with
recombinant IL-4 produce IgG1 and IgE, whereas B cells
activated with LPS plus IL-4 and IL-5 preferentially
synthesize IgA (Coffman et. al. , 1988; Snapper et. al.,
1988) . This situation is also rendered more complex by
the finding that a particular lymphokine not only affects
immunoglobulin isotype, but the amount of lYmphokine also
influences antibody synthesis, e. 
g. 
in vitro synthesis of
IgE requires 10-100 times more IL-4 than that required for
IgG1 synthesis (Snapper et. al. , 1988). LYmphokines can
also have opposing effects. Interferon-gamma suppresses B
cell proliferation that is normally supported by IL-4 and
inhibits the IL-4 mediated synthesis of IgG1 and IgE while
enhancing IgG2a synthesis. Moreover , lYmphokine action is
redundant in that different defined lYmphokines may have
similar effects or provide similar support for B cells.
This is demonstrated by the ability of either IL-4 or IL-5
to support B cell proliferation and differentiation to
antibody secretion (Figure 1, introduction; O'Garra
et. al., 1988; Paul , 1989). In summary, lymphokine action
on B cells is intricate , including interaction among
lymphokines themselves as well as with other types of B
cell stimulators, such as antigen or polyclonal activators
like LPS and anti-Ig.
The action of lymphokines , like that of other
biological mediators , is dependent on the expression of
highly specific receptors which may be either
constitutively expressed or induced as a result of B cell
activation from the resting Go state (see Figure 1,
introduction; review: O'Garra et. al., 1988). Accordingly,
lymphokines can have direct effects on resting Go B cells
acting through constitutively expressed lymphokine
receptors. For example, IL-4 acting through the IL-4
receptor induces a resting Go B cell to undergo a number
of biochemical changes including increased cell size , RNA
and protein synthesis resulting in the induction of new
lymphokine receptors, such as the high affinity chain of
the IL-2 receptor (Loughnan and Nossal, 1989). Because
the process of activation via mitogen or lymphokine
signalling may lead to the induction of new lYmphokine
receptors , a broader range of responses is possible in B
cells that have been previously activated or co-stimulated
wi th other inducers. These considerations suggest that
the specific lymphokines , the concentration of
lymphokines, and the array of receptors expressed at a
particular stage of B cell activation may influence B cell
functions. I have used the assay of B cell support of VSV
infection as a new model system for assaying biochemical
capabilities of B cells exposed to lymphokines. The focus
of the studies presented here is to determine how
lymphokines affect the ability of B cells in different
activation stages (or exposed to different activation
signals) to support VSV infection.
I have previously shown that the ability of B
lymphocytes to support VSV infection is variable and
dependent on the activation state of the host B cell
(Schmidt and Woodland, 1990). Unstimulated B cells in the
o phase of the cell cycle and lymphokine stimulated B
cells in the G1 phase of the cell cycle infected with VSV
- '
demonstrate the same non-supportive characteristics,
including lack of viral pro ein synthesis, infectious
center formation , or PFU production, this despite the
ability of virus to enter these cells. The restriction of
vsv infection in these non-supportive B cell populations
could be at multiple levels, such as 1) release of the
viral nucleocapsid from the endocytotic vesicle, 
primary transcription of viral mRAs , or 3) translation of
the viral mRAs.
studies presented here investigate the
transcription of specific viral mRAs in unstimulated and
lymphokine stimulated populations of B cells to begin to
determine the nature of the block on vsv infection.
lack of viral transcription would suggest a problem with
release of the nucleocapsid from the endosome or host cell
inhibition of viral transcription. Synthesis of viral
mRAs would directly demonstrate that VSV nucleocapsids
are released into the cytoplasm of the B cells and suggest
that synthesis of non-functional mRAs or host cell
inhibition of infection at the level of translation
accounts for the lack of VSV protein synthesis seen in
these B cell populations. The latter possibilities can be
distinguished by testing the translatability of the viral
mRAs produced in an in vitro translation system.
This chapter also evaluates another issue about
lymphokine action on B cells. It is possible that VSV
infection may be restricted by different mechanisms in
unstimulated and lYmphokine stimulated non-supportive B
cell populations (Table 2, Figure 5). Even though
lYmphokines stimulate RNA and protein synthesis, the
similar level of viral support observed with these
populations suggests that metabolic activity 
per se is not
a sufficient signal for " successful" VSV infection. It is
possible that lYmphokine stimulation directly mediates or
induces in these B cells anti-viral effects which mimic
the non-supportive state observed in unstimulated B cells.
Indeed , the converse seems true, as the addition of these
same populations of lymphokines to B cells co-stimulated
with anti-Ig produces a marked enhancement of VSV PFU
production in these B cells compared to those stimulated
with anti-Ig alone (Table 4 , 450 vs. 52 PFUs). However,
the level of infectious virus production never approaches
that found in B cell populations activated with the
mitogen LPS (Table 4 , 450 vs. 5 300). As complex mixtures
of lYmphokines are present in these T cell-derived SNs,
even those from cloned T cell lines, it is possible that
both posi ti ve and negative regulators of VSV
infection/replication are present. As the ability to
repond to lYmphokines is dependent on the presence of and
the level of expression of receptors , cells with different
receptors will likely respond differently to the same
lymphokine mixtures. These considerations suggest that
there may also be another level of variability in regards
to lymphokine action affecting virus expression, i. e. the
ability of B cells to respond to particular lymphokines.
Because activation influences lymphokine receptor
expression, and because different B cell activation
pathways are utilized by anti-Ig and LPS stimulation , it
is possible that variation in expression of lYmphokine
receptors is induced and can subsequently be reflected in
the efficiency at supporting a virus infection.
comparison of VSV infection in B cells co-stimulated with
either anti-Ig or LPS and lymphokines is also carried out
in order to begin to address the possibility that
lYmphokine effects on virus infection vary depending on
the particular activator(s) to which a B cell is exposed.
RESULTS
VSV mRNA transcription in non-supportive B cells
A Northern blot analysis was performed to
determine if the block to VSV infection in non-supportive
B cell populations was at or before primary transcription
of the viral genome. Total cellular RNA was extracted at
9 hours post-infection from B cells cultured for 48 hours
under conditions previously defined as non-supportive
(unstimulated or lYmphokine stimulated) or supportive
(anti-Ig, anti-Ig and lYmphokines or LPS stimulated) for
vsv infection. In addition, RNA was isolated from the
permissive hybridoma cell line 36-65 to serve as a
positive control for all experiments. RNA was separated
by electrophoresis on denaturing gels , blotted onto
nitrocellulose membranes , and probed for primary viral RNA
transcripts. Hybridization was carried out with labeled
cDNA probes specific for each of the VSV gene products
(Figure 6: Panel A , NS mRA; B, G mRA; C , M mRA; D, L
mRA; E, N mRA; and F, ethidium stain). Hybridization to
RNA from VSV infected 36-65 demonstrates that the probes
hybridize with RNAs of the appropriate molecular weight
for each of the VSV genes analyzed (Figure 6, two lanes
labeled 36-65 have 2 and 5ug of total RNA loaded,
respectively) .
RNAs for each viral gene are readily detected in
- -
total cellular RNAs isolated from unstimulated cultured B
cells, lYmphokine stimulated' B cells , anti-Ig and
lymphokine stimulated, and LPS activated B cells (Figure
6, A-E). The paucity o.f viral message found in anti-Ig
stimulated B cells is due to underloading of the gel
(assessed by ethidium stain, figure 6-F); longer exposure
of the film reveals hybridization with each viral probe
(ex. VSV M mRA , figure 6-C). These results indicate that
primary viral transcription occurs in all populations of B
cells examined, including those B cell populations in the
Go and G1 of the cell cycle in which no viral proteins are
synthesized (Figure 3, lane 7). Moreover, the presence of
viral transcripts in unstimulated B cells also supports
the previous conclusion , reached using a different
experimental approach, which suggested that VSV enters all
of the B cell populations examined (Schmidt and Woodland
1990) .
Cul ture of resting B cells with lYmphokines from
helper T cell clones (Th2 SN) also appears to enhance the
level of viral transcription over that seen in
unstimulated B cell populations without affecting viral
protein synthesis. This finding is consistent with the
observation that lymphokine mediated activation of B cells
from a small resting Go cell into the G1 phase of the cell
cycle induces transcription and/or translation of a number
of endogenous genes, increase in cell size, and the total
amount of RNA per cell. For example , resting B cells
stimulated with IL-4 increase transcription and expression
of class II MHC molecules , CD23 (Fc RII), and the IL-4
receptor (Paul, 1989). While VSV mRA transcription is
carried out in the cell cytoplasm by virally encoded RNA
dependent RNA polYmerase and not by the host cell'
enzYmatic machinery, B cells exposed to lymphokines may
upregulate expression of host cell factors which serve to
enhance the efficiency of viral transcription. Thus,
increases in viral mRA levels in G1 B cells may be a
direct consequence of lymphokine stimulation of the B
cells.
An analysis was carried out in order to more
precisely quanti tate the effect of lymphokines on viral
mRA transcription amongst B cell populations. The usual
strategy for such a quanti tat ion is to determine the level
of transcription of selected cellular genes, like actin
and glyceraldehyde-3-phosphate dehydrogenase (GADPH), as a
background for the comparison for viral transcription
levels. However, this approach was complicated by my
finding that the expression of these genes is
differentially regulated during B cell activation. The
Northern analysis in Figure 7 shows that when equivalent
amounts of total RNA , determined by optical density and
ethidium staining, are analyzed the level of actin mRA in
unstimulated B cells (lane 3) is 2-fold higher than that
found in lymphokine stimulated B cell populations (lane
4) . In contrast, the GADPH mRA level in unstimulated B
cells is 2-fold lower than lYmphokine stimulated B cells.
These differences in internal " standard" RNAs made a
straight forward quantitation of viral mRA difficult.
Therefore, viral mRA transcript levels between
unstimulated and lymphokine stimulated B cells populations
were compared by Northern blotting using densitometry and
three analytical conditions: 1) directly measuring
differences in intensity of hybridization when equivalent
amounts of total RNA are probed (Table 7A), 2) comparing
hybridization intensity between viral mRA and viral
genomic RNA when equivalent amounts of total cellular RNA
are probed (this approach assumes that without viral
protein synthesis there is no genomic replication
(Emerson, 1985) and equal virion uptake, (Table 7B), and
3) determining viral mRA levels for equal B cell
equivalents (Table 7C). When analyzed by these three
criteria, viral mRA transcription was 5 to 10-fold higher
in lymphokine stimulated verses unstimulated B cells.
However, lYmphokine stimulation, while resulting in a
marked increase in viral mRA transcription, is not
sufficient for a productive VSV infection. Because
primary viral mRA transcription can occur in B cells
wi thout the synthesis of viral proteins, one block to VSV
infection is likely at the level of translation in Go and
in lYmphokine activated G1 B cell populations.
In vitro translation of VSV mRNAs
The presence of viral mRAs transcripts without
the synthesis of viral proteins demonstrates an inability
to translate viral mRA transcripts. This impairment may
be due to the synthesis of defective viral mRAs (possibly
uncapped or with truncated polyadenylation sequences) or
resul t from host cell mediated translational regulation.
Both mechanisms are known to modulate viral protein
production in other systems. Undermethylation and
suboptimal polyadenylation of VSV mRAs was found to
contribute to the aborted VSV infection of Raj i cells
(Johnson and Herman, 1984), whereas specific host cell
restriction on virus mRA translation has been
demonstrated for mouse mammary tumor virus mRAs (Vaidya
et. al., 1983). In this latter case host-imposed
restrictions are complex, as translational restriction was
associated with three unlinked, independently segregating
genetic loci. In our system, host cell restriction on
translational efficiency is suggested by the finding that
viral mRAs, of appropriate molecular weights compared to
those found in fully supportive B cell populations , are
synthesized in both unstimulated and lYmphokine-stimulated
non-supportive B cell populations (Figure 6). That viral
- -
mRA transcription levels differed between these B cells
wi thout changing the non-supportive phenotype also
supports host cell control at translation (Table 7).
The translatability of the viral mRAs was
assessed in vitro using a wheat germ translation system.
Figure 8 shows the total protein produced by translation
of input RNA from a variety of non-supportive and
supportive B cell cultures. Total RNA isolated from
unstimulated cultured B cells (lane 1) and lYmphokine
stimulated B cells (lane 2 and 3, 1 and 2ug of RNA added
to the translation reaction, respectively) produce , upon
translation, bands of 35S-methionine labelled proteins of
the appropriate size for viral proteins that co-migrate
with proteins produced by the translation of mRA from
fully permissive B cell populations , anti-Ig and SN and
LPS stimulated (lanes 4 and 5 , respectively) and the B
cell hybridoma 36-65 (lane 6). As a standard for viral
proteins , labelled viral proteins produced by VSV
infection of 36-65 are also included (lane 9). The lower
molecular weight of the protein band corresponding to the
VSV G protein produced by in vitro translation (labeled
o) is due to the absence of glycosylation in the wheat
germ system used.
That these translation products were viral
proteins was confirmed by immunoprecipitation of the
translation mixture using rabbit anti-vSV serum (Figure
9) . Viral proteins are precipitated from the translation
products of unstimulated and lymphokine cultured B cell
mRA (lanes 1 and 2) as well as from the translation
products of mRA isolated from fully permissive B cell
populations (lanes 3 and 4).
The amount of G protein found in the 
in vitro
translation products is relatively low in all B cell
populations, including products of mRA from LPS or anti-
Ig and SN stimulated cultures, which fully support VSV
protein synthesis , suggesting a problem of the efficiency
of the translation system rather than the translatibility
of the mRAs. The efficiency may be affected by
competition with other mRAs as well as by the relative
abundance of G mRA in the total RNA pool. The finding
that higher molecular weight proteins in general are
synthesized with lower efficiency by in vitro translation
systems also helps explain this observation.
These data strongly suggest that the lack of viral
protein in unstimulated and lymphokine treated B cell
populations is not the result of defective viral mRA'
being produced in these cells, but rather results from a
translational block that exists in these B cell
populations LYmphokines have been shown to upregulate
both transcription and translation in B cells , but, this
is clearly a specific rather than a generalized effect as
vsv protein translation is not induced by lymphokine
exposure, despite the fact that viral transcription is
enhanced. The data also suggest that lymphokines per se
do not induce the translational block as B cells co-
stimulated with anti-Ig and lymphokines are fully
permissive for VSV.
stimulation with anti-Ig is known to drive B cells
further through the activation/differentiation pathway
than exposure to lymphokines alone. This progression is
accompanied by a new biosynthetic potential of the B cells
which is shown here by the ability of anti-Ig treated B
cells to translate viral mRAs. That the addition of
lymphokines to anti-Ig stimulated B cells enhances VSV PFU
synthesis over that seen with anti-Ig stimulation alone
suggests that lYmphokines may cQ!1plement the activation
events supported by other acti vato , It is also possible
that activation increases the ability to respond by
inducing receptors:on activated cells that were absent on
resting cells , thus increasing the response potential of
the B cells for lYmphokines in the SNs. These differences
in response potential -irt"turn affect the B cell ability to
support virus infection. Some of these possibilities will
be examined in the next section.
contrastinq effects of 1 VIPhokines on VSV expression in
ortive B cell ulations
Anti-Ig activation, which mobilizes the antigen
receptor in a polyclonal fashion on the B cell, induces
cell enlargement and entry into S phase of the cell cycle
without supporting differentiation of the B cell to
antibody secretion. However, the inclusion of T cell
derived lYmphokines enhances proliferation and promotes
differentiation to antibody secretion. This activation
protocol has been frequently used as a polyclonal model
for the events in thymus dependent clonal activation of
antigen specific B cells. It is noteworthy that the
multiple signals required for productive antibody
expression using this pathway are analogous to the
requirements I have established to be necessary to render
B cells fully permissive to support a VSv infection.
cell populations cultured with anti-Ig and lymphokines
support a productive VSV infection.
LPS activation of small resting B cells also
produces a VSV supportive population of cells. LPS
utilizes a different cellular pathway for activation in
which T cell derived lymphokines are not required for
differentiation to antibody secretion. This is used as a
polyclonal model for thymus independent activation of
specific B cells.
Although stimulation with LPS or anti-Ig and
lymphokines produces antibody secreting cells, it is not
known whether all splenic B cells are capable of
responding to each of these inductive pathways or whether
non-overlapping subpopulations of B cells exist which
respond, by antibody secretion, to one but not the other
of these activation pathways. Experiments have
demonstrated that more than 90% of splenic B cells undergo
blastogenesis upon stimulation with either LPS or anti-Ig
(DeFranco et. al., 1982: Phillips and Parker, 1984:
Sieckmann et. al., 1981: Anderson et. al., 1977), yet only
about a third of the stimulated B cells continue to
differentiate to antibody secretion (Ashman, 1984:
DeFranco et. al., 1982), allowing the possibility that the
populations of responding B cells may exist as non-
overlapping subpopulations. That B cells stimulated, by
these thymus dependent and independent pathways produce
different antibody isotypes as well as differ in level of
somatic mutation of their antibody genes is also
suggestive of functionally distinct non-overlapping
subpopulations. To date, however, there has been no
direct demonstration of fundamental biochemical
differences between B cells activated by anti-Ig verses
LPS.
In the experiments previously presented , both of
these activation pathways led to B cell support of VSV
although anti-Ig and lymphokine stimulated cells
consistently synthesize lower levels of PFUs than LPS
activated B cells (Table 4). This may argue that
characteristics intrinsic to a B cell subpopulation or a
consequence of the pathway of activation used to induce
the B cells responding to these stimulators accounts for
differences in observed PFUs. It is also possible that
the diminution in PFUs is due to the counterbalancing
action of the different lymphokines contained in the SNs
used with anti-Ig stimulated cultures. Lymphokine effects
are likely complex, as they could facilitate the full
expression of VSV in some cells , have no effect or
suppress VSV virus synthesis in others , or modulate VSV
expression in the same cell.
since lymphokines work through receptors
differential expression of receptors on B cells may
influence the biochemical capabilities of the cell. The
particular array of lymphokine receptors on B cells may in
part be constitutively expressed as well as expressed at
particular activation stages, induced by a particular
activation pathway, or distributed on distinct
subpopulations. Differences in receptor expression have
been demonstrated. Activation of murine B cells by co-
stimulation with anti-Ig and LPS induces expression of a
high affinity receptor for IL-2 that is not induced with
LPS activation alone (Zubler et. al., 1987). This
expression may reflect either activation pathway or
subpopulation differences. Therefore, the potential
exists for a variable response y B cells to complex
populations of lymphokines, and this ability to respond to
particular lymphokines could influence B lymphocytes to
support virus infection. The use of VSV expression in B
cell populations may be useful as a new model system to
study lYmphokine effects.
To ascertain how anti-Ig and LPS activated B cells
may differ in activity, I determined how the mixture of
lymphokines found to enhance VSV replication in anti-Ig
stimulated cells would affect virus expression in LPS
activated B cells by co-culturing LPS or anti-Ig B cells
with various SNs (splenic , Th1, and Th2) Table 8 , part A
clearly demonstrates the suppression of PFU production
when lymphokines were added to LPS activated B cells, in
marked contrast to the enhancing effects of the same
lYmphokines when added to anti-Ig stimulated B cells.
Inhibi tion was seen with all SN but to a variable extent
the level of suppression being dependent on the lYmphokine
source. Splenic and Th1 derived SNs are completely
suppressive, reducing PFU synthesis to levels seen in
unstimulated B cells, whereas lYmphokines derived from Th2
clones decrease PFU synthesis 10-fold. These differences
are likely due to the presence of a different array of
lymphokine receptors on LPS activated cells that now
allows signalling leading to virus suppression. It is
noteworthy that gamma-interferon , which is known to have
anti-viral effects in many systems, is one of a number of
lymphokines present in SNs from activated splenic and Th1
T cells. Assays performed on stocks of splenic SN showed
20-25 units of interferon activity per ml but did not
distinguish between alpha, beta or gamma forms. Likewise
interleukin-6, present in Th2 SN, was initially termed
interferon-beta2 as a result of anti-viral activity found
in partially purified cytokine preparations , although
subsequent studies using recombinant molecules have not
demonstrated anti-viral effects (Van Damme et. al., 1987).
LYmphokines, in particular interleukin-4 and gamma-
interferon, have been shown to have opposing effects on B
cell differentiation and antibody production (0' Garra
et. al., 1988), and gamma-interferon has been demonstrated
to be a growth factor and not an anti-viral factor for T
lymphocytes (Landolfo et. al., 1988). Therefore, while
lYmphokines with known anti-viral activity on some cell
types are present in some of the SN preparations used in
these experiments, it is also possible that new
unappreciated anti-viral effects of already defined
lymphokines or undefined anti-viral lYmphokines are
present in these SNs , and that the expression of these
anti-viral effects in B cells is dependent on the
activation pathway inducing specific combinations of
receptors.
Is any anti-viral activity associated with
constitutively expressed lymphokine receptors or is the
suppression seen the result of LPS induced receptors?
answer this question, B cells were exposed to lYmphokines
for 24 hours , washed and stimulated with LPS for 48 hours
to see if there was an effect on their ability to support
virus infection. Table 8, part B demonstrates that
exposure to various lymphokine mixtures for 24 hours prior
to LPS stimulation suppresses PFU synthesis between 4 and
10-fold when compared to B cells activated with LPS alone.
Overall, suppression is not as dramatic as that seen upon
continuous lymphokine exposure. As the lymphokines were
removed from the B cell cultures prior to the addition of
LPS to the cells , suppressive effects may have been
minimized by a short action time of suppresive factors.
However, I favor the hypothesis that there are differences
in the array of receptors for particular lYmphokines
between resting and activated B cells and that the LPS
induced lYmphokine receptors are responsible for the anti-
viral activity seen. These results demonstrate that the
activity of lymphokines on VSV expression is dependent on
the B cell population analyzed and is directly affected by
the activation pathway through which B cells are induced.
DISCUSSION
These experiments have demonstrated that
unstimulated and lymphokine stimulated B cell populations
that do not support VSV protein synthesis do support
transcription of VSV viral mRAs (Figure 6). The viral
mRAs synthesized can be translated in a wheat germ
translation system indicating that the lack of viral
protein synthesis in infected B cell cultures is not due
to mRNA defects but rather due to translational control
imposed by the B cell populations. Host cell control at
the translational level has been observed for viral mRNAs
expression in murine mammary tumor virus infected cells
(Vaidya et. al. , 1983). other investigators have shown
that expression of two out of five growth-related proteins
analyzed in primary lung epithelial cell cultures is
controlled at the level of translation but not
transcription during cell proliferation and
differentiation. Translation of the growth-related genes
in these epithelial cell cultures is regulated by growth
factors found in serum, and the cellular response to the
factors, which influence translation is dependent on the
stage of differentiation of the epithelial cell (Clementi
et. al., 1990). Likewise, during B cell activation,
changes in translational control may oc ur as the result
of different activation signals (lYmphokine verses anti-
Ig) or at different stages in the activation/
differentiation pathway (G1 verses S phase of the cell
cycle) . To further characterize the level of
translational control, an analysis of the association of
viral mRA with polysomes is necessary to evaluate whether
translation is blocked at elongation or initiation.
Controls at the level of viral transcription are
also seen in B cells. The amount of VSV mRA synthesized
in unstimulated B cells is 5 to 10-fold lower than in
lymphokine stimulated B cells when equivalent amounts of
RNA are analyzed (Figure 6, Table 7). Al though
quanti tat ion is not straight forward in this system, a
number of possibilities can be envisioned to account for
differences in virus transcription levels in non-
supportive populations. The general physiological state
of unstimulated cultured B lymphocytes may differ from
lymphokine activated B cells. These differences may
include an overall lower metabolic rate for B cells in the
Go phase of the cell cycle, lower nucleotide pools
inhibi tors of transcription , or the generally poor
viability of B cells cultured without stimulation. These
are all changes that could effect the rate of
transcription of both host and viral mRAs. Perhaps more
interestingly, lymphokine exposure may directly enhance
transcriptional efficiency in a virus-specific fashion by
removing existing blocks to virus transcription or
directly enhancing the efficiency of the viral polYmerase
with specific host factors.
To attempt to address whether the general
physiological state of unstimulated B cells after 48 hours
in culture is the cause of the lower transcription levels
a comparison of virus transcription levels in freshly
isolated and cultured unstimulated B cells can be done.
caveat exists to this experiment; although both of these
populations have the same VSV non-supportive
characteristics (Table 4), it is not clear that the
population of cells that survive unstimulated culture
conditions are representative of the whole starting
population. Therefore, possible changes in transcription
levels over culture time may represent cell population
selection rather than changes in the physiological state.
It is also conceivable that only a few B cells in the
unstimulated population are carrying out high levels of
transcription while other B cells are blocked at other
stages of VSV infection , uncoating or transcription.
si tu hybridization can be used to address this question by
examining both the number of cells and levels of
transcription in unstimulated or lymphokine stimulated
populations.
The differential activity of lymphokines on B cell
populations which have received different activation
signals is demonstrated by a number of observations.
LYmphokine populations which alone do not activate B cells
to support VSV mRNA translation markedly enhance VSV PFU
synthesis in B cells co-stimulation with anti-Ig,
suggesting that the effect of lymphokines can be dependent
on the B cell activation state (Table 4). Second , the
lYmphokine populations that will enhance VSV PFU synthesis
upon co-culture with anti-Ig suppress PFU synthesis when
added to cells activated with LPS suggests that the
activator to which the B cells have been exposed markedly
influences the B cell response to lYmphokines (Table 9 A).
Third, pretreatment of B cells with lymphokines prior to
LPS activation results in depressed levels of VSV
expression when the B cells are subsequently activated by
LPS (Table 9). The suppression seen with lYmphokine
pretreatment is markedly less than that seen when cells
are co-cultured with LPS and lymphokines , suggesting that
these results are likely a reflection of the unique array
of lymphokine receptors displayed by these B cells.
LYmphokines act through receptors that are either
consti tuti vely expressed on B cells or induced by
activation . If receptors are induced, the pathway of
activation could determine the spectrum of receptors
expressed as well as differentially regulate the final
level of receptor expression. The pathway of B cell
activation has been shown to selectively influence the
expression of a number of surface glycoproteins which have
known or suspected receptor function. Anti-Ig stimulation
increases the level of CD5 expression on B cells known to
be CD5- before induction whereas LPS had no effect on CD5
expression (Freedman et. al. , 1989; wortis et. al., 1990
abstract, personal communication) and the expression of
high affinity IL-2 receptors is induced on B cells by co-
stimulation with anti-Ig and LPS but not by LPS
stimulation alone (Zubler et. al., 1987). These resul ts
support the notion that the activation pathway can
influence the array of receptors expressed on a single B
cell population.
There is another possible level of complication.
While both LPS or anti-Ig and lymphokine activation
produce antibody secreting cells, it is unknown whether
all splenic B cells are capable of responding to either of
these stimulators or whether non-overlapping
subpopulations of B cells exist which can respond to only
one of these activation pathways. If differentially
activatable subpopulations of B cells exist, they could
express different arrays of receptors constitutively or
upon induction. Therefore , not only the process of
activation but also the potential activator influences
receptor expression. That B cell support for VSV is
responsive to these differences presents a working system
that allows for a full analysis of lYmphokine receptor
signal transduction. There are a number of models for B
cell activation which can account for the opposing effects
of lYmphokines on B cell support of VSV that I have noted.
Figure 10 depicts three response schemes that
attempt to incorporate the various action of lYmphokines
observed in this system. scenerio A utilizes a single
population of B cells which exists as a functionally
homogeneous population responsive to either anti-Ig or
LPS. Depending on the inducer, a different array of
lymphokine receptors , with some potential for overlap
(i. e. lYmphokine receptor D), is displayed and confers a
unique response "phenotype" of the B cells response to a
lYmphokine mixture. Depending on the biochemical
pathway (s) induced in the host following receptor-
lYmphokine interaction , either enhancement or suppression
of virus can occur. scenario B represents a model where
two distinct subpopulations of B cells , each of which is
responsive to only one activator. These B cell
subpopulations are restricted in the array of induced or
constitutive lYmphokine receptors they express , thereby
facilitating the positive or negative effects on virus
replication. scenario C represents two subpopulations of
B cells which can respond to either anti-Ig or LPS , but
activation by one pathway enhances the level of expression
of certain receptors displayed over the level of
expression induced when the other pathway is engaged thus
allowing for opposing lymphokine effects.
Models A and C, which assume the ability of the
host B cell to respond to both activators , are consistent
with the observation that 90% of B cells undergo
blastogenesis upon exposure to either activator while only
a fraction of those cells continue to differentiate to
antibody secretion. The ability to respond to both anti-
Ig and LPS is also consistent with the finding that the
addition of anti-Ig to LPS activated B cells inhibits
differentiation, but not proliferation of LPS activated B
cells (Flahart and Lawton, 1987; Seyschab et. al., 1989).
This inhibition of LPS activation by anti-Ig is directed
at the transcription of differention-related genes
(Flahart and Lawton, 1987).
Further experiments using recombinant lymphokines
either alone or in combination with either anti-Ig or LPS
activation can be done to define the enhancing or
suppressive effects of particular known lYmphokines and
may also define new functions for these molecules. The
possibility also exists that undefined lymphokines present
in these SNs may be responsible for some of these
activities.
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Table and Fi ure le ends
Table 7
Level of viral mRA synthesis was determined by
density scanning techniques on 2 different exposures of
film for each probe on B cell populations shown in figure
Only those lanes containing 10 ug of total RNA were
analyzed and include B cell populations cultured for 48
hours without unstimulation or stimulated with lymphokines
(SN), anti-Ig + SN, and LPS. All values determined
relative to the unstimulated B cell population signal.
a B cell equivalents defined as the number of B
cells represented in 10 ug of the total amount of RNA
extracted from a known number of B cells. , anti-Ig +
SN, and LPS values were scored relative to the
unstimulated population.
Table 8
a In part A, small resting B cells were cultured
with the indicated stimulus for 48 hours prior to virus
infection. In part B, small resting B cells were cultured
for 24 hours with the first stimulus shown, washed and
stimulated for an additional 48 hours with LPS.
b PFU synthesis per 103 cells cultured , mean of
duplicate determinations averaged over two serial
dilutions.
F i ure 6
Small elutriated B cells were cultured 48 hours
wi th the indicated stimulus prior to infection. Total RNA
was extracted 9 hours post-infection for Northern
analysis. 10 ug of total RNA was loaded for unstimulated
lymphokine stimulated (SN), anti-Ig + SN, and LPS samples;
2 and 5 ug from 36-65 control cells; and approximately 2
ug from anti-Ig stimulated cells. Probed for VSV mRAs:
panel A - NS mRA, panel B - G mRA, panel C - M mRA
panel D - L mRA, panel E - N mRA, and panel F - ethidium
stain.
ure 7
Nothern analysis of total RNA extracted 9 hours
post-infection from B cells cultured for 48 hours with the
indicated stimulus and probed for actin and GADPH mRA
synthesis. Lane 1 and 2 , 2 and 5 ug 36-65; lane 3
unstimulated, cultured B cells; B cells stimulated with
lane 4, lYmphokinesi lan , anti-Ig; lane 6, anti-Ig +
lymphokines; and lane 6 , LPS.
iqure 8
In vitro translation using a wheat germ system of
total B cell RNA extracted from: lane 1, unstimulated
cultured cells; lanes 2 and 3 , lymphokine stimulated , lane
4, anti-Ig + lYmphokine; lane 5 , LPS stimulated; lane 
36-65 control and lane 7, no RNA added. Lanes 8 and 9 are
un infected and VSV infected 36-65 cells , respectively,
that were labeled with 35S-methionine in vivo
iqure 9
Immunoprecipi tation of translation products with
rabbit anti-NDV serum. Protein products from translation
of RNA from lane 1, unstimulated cultured B cells; lane 2
lYmphokine stimulated; lane 3, anti-Ig + lYmphokine
stimulated; lane 4 , LPS stimulated; and lane 5, hybridoma
36-65. Lanes 6 and 7 are precipitations from un infected
and infected 36-65 cells , respectively, labeled in vivo
Figure 10
Models for B cell activation.
TABLE 7
OMPARISON OF VSV mRNA LEVELS
METHOD OF COMPARIS 
: direct comparison of mRNA
PROE:
unstimulated 1.0
SN (COC 35)
mRNA intensity relative to genomic
PROBE:
unstimulated
SN (COC 35)
: mRNA : B cell equivalents
PROBE: actin GAOPH
u nsti m u lated
SN (COC 35) 11.
anti- Ig + SN 23. 29. 32. 22.4
LPS 13. 28. 17. 10. 34.
TABLE 8
YMPHOKINES AND VIRUS SUPPRESSION
PFUTIMUL S a STIMULUS PFU
LPS 160 ANTI-
LPS + Sp SN ANTI- Ig + Sp SN 450
LPS + Th2 SN 230 ANTI- Ig + Th2 SN 908
LPS + Th1 SN ANTI- Ig + Th1 SN 264
LPS -:; LPS 280
Sp SN -:; LPS 668
Th2 SN -:; LPS 160
Th1 SN -:; LPS 626
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CHAPTER 3
VSV expression in partiallv supportive B cells
INTRODUCTION
B cells activated with anti-Ig, at concentrations
which allow entry into the S phase of the cell cycle
support the synthesis of VSV proteins (Figure 3) and an
increased number of infectious centers but produce few
PFUs (Tables 4 and 5). These characteristics of VSV
infected anti-Ig stimulated B cells are phenotypically
similar to those found when other cell types undergo
persistent infection with viruses (Younger and Preble
1980) . Persistently infected cells may serve as
reservoirs for virus , constantly shedding low levels of
infectious virus particles or possibly converting to an
acute lytic state upon activation under the appropriate
conditions . For example , human B lymphoctes persistently
infected with EBV can be induced into a lytic infection by
stimulating the B cells with anti"'tg_ (Crawford and Ando,
1986) .
Mechanistically, persistent viral infections may
be due to host imposed restrictions on virus replication
and/or the s lection of virus variants. virus variants
may bear mutations in Ol1e or a number of viral genes which
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can result in loss of expression of a viral protein or the
alteration of protein function , producing such changes as
the predominant synthesis of defective interfering virus
particles or the inappropriate localization of viral
proteins (Youngner et. al., 1978; Youngner and Preble,
1980) . In vivo , virus variants causing persistent
infections must escape immune system detection , without
being cytopathic for the host cell. Al teration of protein
localization during persistent infection has been
demonstrated in newborn mice infected with lymphocytic
choriomeningitis virus. During this persistent infection
viral glycoproteins are not found on the surface of
infected cells 30 days after infection , thus aiding in the
escape from immune system surveillance. During the first
two weeks of LCMV infection the expression of viral
glycoproteins on the host cell surface was similar to that
of acutely infected cells , suggesting that either the
immature immune system of newborn mice or some other
mechanism for eluding immune surveillance , such as short
lived immunological tolerance, permitted establishment of
the persistent infection (Oldstone and Buchmeirer, 1982).
In vitro , the expression of the persistently infected
phenotype usually requires the outgrowth of a clone or
clones of cells originally infected with a viral variant
I!'
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produced during an acute infection (Youngner et. al. , 1978;
Welsh and Oldstone , 1977; Old stone and Buchmeier , 1982).
Host imposed restriction on virus infection is
seen in the failure of host cells to support a number of
primary viral infections. Inhibition of replication of
viral genomic RNA has been observed during VSV infection
of non-permissive rabbit cornea cells (Hamilton et. al.
1980) and the human B cell line , Ra j i (Johnson and Herman
1984) . Persistent VSV infections are also readily
established in EBV-positive but not EBV-negative human B
cell lines by an as yet unknown mechanism that does not
apparently involve viral genomic replication (Creager
et. al. , 1982). Kinetics suggest that the phenotype of
persistently infected cells observed with VSV infection
during primary infection (24 hours post-infection) of
anti-Ig stimulated B cells is likely the result of host
cell imposed restrictions on VSV infection rather than
selection of virus variants. Host B cell control of the
outcome of VSV infection is further supported by
preliminary evidence showing that the addi ion of
lYmphokines (Th2 SN) to VSV infected B cells after their
stimulation for 48 hours with anti-Ig alone results in
high level PFU synthesis. VSV infected anti-Ig stimulated
B cells gave 38 PFU per 103 cells when cultured without
l"I'
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additional stimulus and produced 1300 PFU per 103 cells
when Th2 SN was added to the infected cell cultures 
cells co-cultured with anti-Ig and lymphokines produced
780 . and 1130 PFU per 103 cells with and without SN,
respectively) . These results demonstrate that further
activation of the infected anti-Ig stimulated B cells
supported by lymphokines induces cellular changes which
can then support VSV PFU synthesis at a level equivalent
to that observed when B cells are co-stimulated with anti-
Ig and lYmphokines prior to infection.
Effects on virus infection or replication that are
the consequence of either host cell restrictions or
mutational events can result in 1) a lower level of viral
transcription in persistently infected cell lines when
compared to lytically infected cell lines (Creager et. ale ,
1981) or selective impairment of a particular mRA
transcript due to lower transcription levels or increased
degradation (Vaidya et. al., 1983), 2) deficiencies in
viral protein synthesis or inappropriate cellular
localization of viral proteins (vaidya et. al. , 1983; Welsh
and Buchmeier, 1979; Oldstone and Buchmeier, 1982; van der
Zeijst et. al., 1983), 3) inhibition of replication of the
viral genome (Nowakowski et. al., 1973; Johnson and Herman
1984; Hamilton et. al., 1980), and 4) defective maturation
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of virus particles (Youngner and Preble , 1980; Me1tzer
et. al. 1990). Anti-Ig stimulated B cells support the
synthesis of the complete array of VSV proteins and low
levels of PFU synthesis suggesting that the block to high
level PFU synthesis is at a point beyond viral protein
translation, such as inappropriate cellular localization
of viral proteins , genomic replication, virion assembly or
maturation. Although previous experiments demonstrated no
apparent deficit in a particular viral protein when
infected cell lysates were immu loprecipitated with rabbit
anti-VSV serum (Figure 3), these precipitations were not
truly quantitative , making it possibile that selective
defects in protein synthesis could produce the phenotype
of low PFU synthesis. Limi ted protein synthesis could
result from a generalized or specific decrease in VSV mRA
transcripts or by host cell translational control. The
following experiments address the first mechanism of
persistence previously discussed by determining the level
of viral mRA synthesized in anti-Ig stimulated B cells.
RESULTS
VSV mRNA transcription in anti-Iq activated B cells
A possible restriction on PFU synthesis in VSV
infected anti-Ig stimulated B cells may be a limitation on
108
the transcription of either some or all VSV genes. This
would limit the amount of required viral protein (s)
leading to low levels of VSV replication. To address this
question the synthesis of VSV mRA' s was analyzed by
Northern blotting of total RNA extracted from lymphokine
anti-Ig, anti-Ig plus lymphokine , and LPS stimulated B
cell populations. The results of this analysis , shown in
figure 11 (A - ethidium stain, B - L mRA, C - G mRNA, D -
M mRA, E - NS mRA, and F - N mRA), shows that probes
for all viral mRAs readily hybridize with mRA extracted
from anti-Ig stimulated B cells. No apparent deficit in
any one viral mRA or in the overall amount of viral
mRAs , assessed by density scanning, is observed when the
viral mRAs from anti-Ig stimulated B cells are compared
to mRAs from permissive B cell populations (anti-Ig and
lYmphokines or LPS). Moreover , no differences were noted
when hybridization was compared with non-permissive
lYmphokine stimulated B cells.
The pattern of viral protein synthesis observed
with 35S-methionine labeled extracts of VSV infected anti-
Ig stimulated cell cultures (figure 3 , lane 2) is
consistent with the production or VSV mRAs. Moreover, no
obvious deficit in the synthesis of any viral protein is
seen when limiting amounts of infected cell lysates are
".'-
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immunoprecipitated with excess antibody to VSV proteins.
Al though not precisely quanti tati ve , this technique
provides an overall assessment of viral protein synthesis
and a significant deficit in synthesis of any viral
protein would have been detected. Therefore , it is
unlikely that anti-Ig stimulated B cells limit VSV
replication by translational control as was seen for
unstimulated and lymphokine stimulated B cell populations.
These findings suggest that the low level of PFU
production by B cells activated with anti-Ig is most
likely due to a restriction on VSV infection at a point
beyond primary transcription and translation, and suggests
the need for other analytical approaches to determine the
site of restriction in PFU synthesis in anti-Ig stimulated
B cells. These approaches are presented as the
discussion.
DISCUSSION
VSV qenomic replication in anti-Iq activated B cells
Replication of VSV genomic RNA is required for
both the amplification of infection within a cell as well
as the synthesis of virions. Replication involves the
synthesis of positive-sense copies of the viral genome,
which are then used as templates for the synthesis of
negative-strand viral RNA, which can be packaged into
li.
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progeny virions. The process of replication is dependent
on ongoing viral protein synthesis , in particular the VSV
and NS proteins (review: Wagner, 1990). In vitro
replication studies also suggest the involvement of host-
cell factor(s) in replication as nucleocapsids and
cytoplasmic protein fractions from VSV infected cells were
most efficient for in vitro replication (Peluso and Moyer,
1988) . Restriction on VSV RNA replication has been
observed in the non-permissive infection of rabbit cornea
cells (Hamilton et.al., 1980) and in some B lYmphoblastoid
cell lines (Nowakowski et. al. , 1973; Johnson and Herman,
1984) . Therefore , it is possible that the synthesis of
either positive or negative sense replicative forms of VSV
genomic RNA is deficient in anti-Ig activated B cells
resul ting in the low level PFU synthesis.
In primary B cells, viral RNA replication can be
directly assessed with Northern analysis and the use of
probes specific for either positive or negative sense VSV
genomic RNA species. I have taken the initial steps to
approach this question by cloning a portion of the VSV G
cDNA clone into a Bluescript vector so that RNA probes for
either positive or negative sense strands of VSV can be
prepared by in vitro transcription using T3 or T7 RNA
polYmerases. Synthesis of positive-strand virion forms in
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anti-Ig stimulated B cells can be directly examined and
compared with synthesis levels of positive sense RNA in
the fully supportive B cell populations. The analysis of
negative-strand genomic RNA synthesis requires that the
level of input (infecting) genomic RNA, which is of
negative sense, be used as a measure of background in
order to assess increases in this RNA species. Input VSV
genomic RNA will be quantitated by hybridization with the
negative-strand specific probe to RNA samples from B cells
harvested one hour post-infection. As the level of
negative-strand synthesis increases over the time of
infection , a comparison of the input genomic RNA with the
amount of negative-strand RNA found at later times in
infection will be used for this assessment. Because the B
cell populations used for these analyses vary in the
number of cells producing virus, assessed by infectious
center assay (Tables 4, 5), as well as in the amount of
RNA per B cell , cellular RNA content increases during
activation, a correction must be included in the analysis.
A comparison of the level of viral genomic RNA synthesis
relative to the number of B cells producing infectious
centers in the same B cell population or a comparison
based on the number of B cells represented by the amount
of RNA analysis by hybridization (calculated according to
. .
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the total amount of RNA extracted for the given number of
B cells in the population extracted) must be done to
analyze population differences. This analysis should
indicate if the low level of PFU production in anti-Ig
stimulated B cells can be attributed to restrictions on
the synthesis of positive or negative genomic forms.
The possibility also exists that anti-Ig
stimulated B cells preferentially synthesize and package
defective rather that full length genomes. Because
defective interfering particles (D. I) are not infectious
the production of defective interfering (D. I. ) particles
could explain the low level of PFUs detected from anti-Ig
infected B cells. While D. I. particle synthesis usually
increases over time in a persistent infection or is
observed early in infection when infections are done at
high multiplicities of infection or with virus populations
containing high levels of D. I. particles (Youngner and
Preble, 1980; Youngner et. al., 1978), anti-Ig stimulated B
cells may promote D. I. synthesis either by failing to
provide a required host cell factor for stabilization of
the replication complex or by directly inhibiting
synthesis of full length genomic RNAs by destabilizing the
viral polymerase during replication. since D. I. genomes
are packaged into virus particles , an analysis of the RNA
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species in particles released into the culture SN from
infected anti-Ig stimulated B cells can be done to examine
this question. D. I. genomes contain incomplete viral RNA
sequences , 50% or less of the standard genome that include
simple deletions or snap-back forms which contain
sequences complementary to both positive and negative
genomic sense RNA. Because virion RNA from infectious
virus particles should be of uniform size and polarity,
the finding of packaged , smaller size RNAs or RNA species
containing sequences complementary to posi ti ve- and
negative-sense probes would suggest synthesis of defective
forms. To examine this possibility, viral RNAs produced
in anti-Ig stimulated B cells can be directly labeled with
3H-uridine, released particles pelleted from the culture
SN and examined for size by electrophoresis on denaturing
urea -acrylamide gels. Alternatively, unlabeled RNA can be
extracted from SN pellets and subj ected to Northern
analysis. The use of probes specific for either positive
or negative sense genomic RNA would allow the detection of
packaged RNA species of different sizes as well those
which contain sequences complementary to both senses of
RNA demonstrating synthesis of the snap-back form of D. I.
particles.
VSV protein localization in anti-Iq activated B cells
L-= 
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viral protein maturation or localization in anti-
Ig stimulated B cells may not be appropriate for formation
of VSV particles , serving as an alternative or additional
point of restriction on VSv infection. The VSV-G
glycoprotein requires oligomerization in the endoplasmic
reticulum for efficient transport to the plasma membrane.
This requirement has been established by demonstrating
that G protein mutants, incapable of forming oligomers,
are either transported inefficiently or not at all (Kreis
and Lodish, 1986; Doms et. al., 1987; Doms et. al. , 1988).
In addition, other VSV proteins are required at sufficient
levels for virus replication, e.g. enough VSV N and NS
proteins must be available to associate with and cover the
viral RNA during genomic replication. The VSV-M protein
is involved in virion maturation by binding to replicated
nucleocapsid structures in the cell cytoplasm. This
complex then migrates to the cell membrane , and the M
protein mediates association with membrane areas
containing the G protein (review: Wagner , 1990).
Therefore, the low PFU production seen in anti-Ig
stimulated B cells may reflect a host-imposed inability to
support or a direct inhibition of viral protein maturation
or complex formation.
Oligomerization of the G glycoprotein requires the
J. 
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participation of a host cell derived component. The host
heavy chain binding protein (BiP , also called glucose
regulated protein 78, GRP78 , Munro and Pelham , 1986) is
involved in the process of protein oligomerization of the
native VSV G-glycoprotein (de Silva et. al., 1990).
BiP/GRP78 is a member of a family of stress proteins and
its expression is induced during B cell activation (Wiest
et. al., 1990), glucose starvation (Shiu et. al. , 1977),
virus infection (Collins and Hightower, 1982; Garry
et. al., 1983; Sarnow, 1989), and with calcium ionophores
(Watowich and Morimoto, 1985). This cellular protein is
required in B cells for the oligomerization of heavy and
light chains during antibody formation (Hendershot et. ale ,
1987) . It is noteworthy that the differentiation of B
cells to high level synthesis and secretion of
immunoglobulin, supported by the addition of lymphokines
to anti-Ig stimulated B cells , are also the additions
necessary for increased VSV PFU synthesis when B cells are
infected. Therefore, it is possible that the level o Bip
in anti-Ig stimulated B cells may be insufficient for
efficient VSV-G glycoprotein assembly.
Cellular proteins besides BiP are also induced
during B cell activation (Wiest et. al. , 1990) and may be
involved in enhancing or inh.ibi ting viral protein
f. 
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localization or assembly of virions. Host cell proteins
also members of stress protein families (hsp and grp
proteins), have been identified that are involved in
assembly and transport of protein complexes or associated
with cell receptors (Young, 1990). Enhanced expression of
some of these stress proteins , even during virus mediated
shut-off of other host cell protein synthesis , as well as
the co-precipitation of viral proteins with stress
proteins have been detected in virus infected cells
suggesting that these cellular proteins can play an
important role during virus infection (Collins and
Hightower , 1982; Garry et. al., 1983; - Sarnow, 1989). For
example , the VSV N protein has been coprecipitated with
anti-hsp90 antibodies from infected chick embryo cells
(Garry et. al., 1983). Therefore, viral protein maturation
or localization can be affected at a number of levels by
changes iri protein expression during the B cell activation
process.
To begin to address the question of protein
localization in B cell populations, the expression of the
VSV-G protein on the cell surface will be examined.
Surface staining, using a monoclonal antibody specific for
the VSV-G glycoprotein (kindly provided by Dr. C. Reiss)
will be used to assess whether anti-Ig stimulated B cells
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are deficient in surface expression of the G protein.
failure in surface staining or low level of staining
compared to permissive B cell populations would suggest
that there may be a problem in protein transport or
oligomerization , possibly involving expression of Bip in
anti-Ig stimulated B cells. Immunoprecipi tat ion of the G
protein , using the monoclonal antibody, from infected cell
lysates followed by SDS-gel electrophoresis under non-
reducing conditions can be done to determine whether
protein oligomerize of G is occuring. Since Bip is
required for VSV-G protein association
, a failure to
oligomerization would suggest that anti-Ig stimulated B
cells are deficient in this cellular protein. The
synthesis of Bip in anti-Ig stimulated B cells and its
association with VSV-G protein during infection can be
examined by immunoprecipitation with anti-Ig antibody or
anti-Bip antibody (kindly provided by L. Hendershot).
either the rate or overall synthesis of Bip is low in
anti-Ig stimulated B cells
, longer 35S-methionine labeling
times or even labeling of cellular proteins prior to
infection may be required in order to label sufficient Bip
for this analysis.
A general analysis of other cellular stress
proteins expressed during different B cell activation
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states as well as those cellular proteins found associated
with viral proteins , such as VSV N with hsp90, may provide
insights into restrictions on support of VSV infection by
B cells. Previously, infected cell lysates were prepared
following alkylation with iodoacetamide , which may have
disrupted protein-protein interactions. Therefore
immunoprecipitation with anti-stress protein antibodies
and/or anti-VSV antibodies from cell lysates prepared
wi thout alkylation may be useful for the detection of
interactions between B cell proteins and VSV proteins.
stress proteins bind ATP so that a method for examining
their general expression in B cells exposed to different
activators can be carried out by using affinity
chromatography followed by gel electrophoresis of labeled
cell lystaes.
VSV article maturation in anti-I activated B cells
The proper maturation of virus particles may be
the limiting step in VSV infection of anti-Ig stimulated B
cells. Virus particles may not be formed, may be formed
properly but not released, or formed improperly.
these possibilities can be directly addressed
Each of
experimentally.
Previous assays for PFU synthesis have been done
by simply collecting SNs from cultured cells. An initial
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examination of PFU synthesis from cell populations where
viral SNs are collected with and without freeze thawing of
the B cells may indicate if the problem is associated with
release of virions from the cell surface. Assembly of
viral components , such as an inability of the nucleocapsid
to associate with the plasma membrane, could result in a
lack of particle formation. This would most likely result
from interference by components of the host cell membrane
causing inhibition of maturation or release of mature
virions. An electron microscopic examination of anti-Ig
activated B cells can be done to see if assembly of virion
nucleocapsids is occuring at the cell membrane.
If virus particles are produced by infected anti-
Ig stimulated cells , the amount of glycoprotein
incorporated into the virion, protein composition of the
nucleocapsid, or some affect of the host cell plasma
membrane components (lipid or protein) may affect
subsequent PFU detection. Changes in virion composition,
such as limited numbers of viral glycoproteins , have been
shown to alter virulence, affect viral tropism and target
cell susceptibility for a number of viruses, including HIV
(Meltzer et. al. 1990) and NDV (Sheehan et. al., 1987).
look at this possibility, an analysis of the protein
composition of virions can be done by continuous labeling
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of proteins during B cell infection with subsequent
pelleting of released virus particles and analysis by SDS-
gel electrophoresis. A comparison of protein composition
of virions from anti-Ig stimulated B cells and permissive
B cell populations may indicate if this is a point of
restriction.
It is also possible that the rate of virion
assembly in anti-Ig stimulated B cells is slower than in
anti-Ig plus lymphokine stimulated cells. The addition of
lymphokines to anti-Ig activated B cells does induce
higher rates of antibody synthesis and may induce critical
host cell proteins required for efficient transport,
assembly of virion components , or alterations in membrane
fl uidi ty . As the assessment of PFU synthesis has been
done at 24 hours post-infection, any rate differences
might give the impression of lower synthesis. Examination
of PFU production up to 72 hours post-infection or even an
analysis of the replication of genomic RNA over a
prolonged period of time may indicate if this is cause of
low PFU synthesis.
In summary, VSV infection of anti-Ig stimulated B
cells presents a pattern of virus expression similar to
persistently infected cells , i. e. viral protein synthesis
without PFU production. Analysis of VSV infection in B
121
cells in this activation state may present a new model for
systematically analyzing the influence of possible host
cell-derived factors on virus infection in primary cells
where the outcome of infection is host controlled and
reliably obtained.
'''
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Fiqure leqend
Fiqure 11
Total RNA was extracted 8 hours post- infection
from the control B cell hybridoma 36-65 and from B cell
populations stimulated for 48 hours prior to VSV infection
with the indicated stimulus (lymphokines (SN), anti-Ig,
anti-Ig + lymphokine , and LPS). Samples of RNA, 2ug from
36-65 and 10ug from the B cell populations , were separated
by agarose-formaldehyde gel electrophoresis , processed
(see methods) and probed for VSV mRAs: Panel B - L mRA
panel C - G mRA, panel D - M mRA, panel E - NS mRA, and
panel F - N mRA. Panel A is the ethidium stain.
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CHAPTER 4
NDV INFECTION OF B LYMPHOCYTES
INTRODUCTION
Experiments previously described have defined a
system suitable for the analysis of the activation
requirements necessary to render B lymphocytes capable of
supporting a virus infection. These data showed multiple
restrictions on a productive VSV infection that were
dependent on the activation signal (s) a B cell population
had received. It was of interest to determine if the
conditions established for a productive VSV infection were
equivalent to those necessary to support other viruses , as
it was felt that such a comparison could provide new
insights into the process (es) by which lYmphocytes are
rendered into permissive hosts for virus infection. NDV
a member of the paramyxovirus family of negative-stranded
RNA viruses which includes parainfluenza, mumps, measles
and respiratory syncitial virus, was chosen for the first
comparative analysis.
The NDV virion, like VSV, is composed of a
lipoproteip envelope surrounding the nucleocapsid core.
The single stranded RNA genome encodes six viral proteins,
undergoes cytoplasmic replication with virion assembly at
'6t
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the host cell plasma membrane , and is dependent on host
";'
cell factors for these processes (general review:
Kingsbury, 1990). Both NDV and VSV undergo permissive
lytic infections in a number of the same cell types , such
as primary chick embryo fibroblasts , CHO cells , the
myeloma SP2/0 , and the hybridoma 36-65; all have been used
as control target cells in our experiments. Since NDV
lytically infects chick embryo fibroblasts , the same
infectious center and PFU assay systems set up for VSV can
be used to assess B cell support for NDV infection.
Al though both paramyxoviruses and rhabdoviruses
have similar replication patterns , some important
differences have been observed. One distinction between
NDV and VSV infection is the route of entry of the virus.
The NDV F surface glycoprotein mediates fusion between the
virus and cell membranes. This releases the nucleocapsid
directly into the cell cytoplasm, as opposed to the
requirement for endocytosis of the VSV virion. Spread of
infection by the paramyxovirus family can occur not only
through the dissemination of infectious particles , but
also by fusion between infected and un infected cells
mediated by the viral F glycoprotein (Gallaher and Bratt
1974). viral protein mediated fusion results in syncitia
formation wi thin the host and is in part responsible for
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the viral cytopathology associated with a number of viral
diseases induced by paramyxoviruses (NDV , respiratory
syncitial virus, measles), as well as other viruses,
including coronaviruses (mouse hepatitis virus), and
retroviruses (HIV).
A second difference found between NDV and VSV
invol ves the surface expression of viral glycoproteins.
Experiments using polarized cells demonstrated that the
rhabdovirus glycoproteins were expressed on the
basolateral cell surface , whereas paramyxovirus
glycoproteins were expressed on the apical surface
(Rodriguez-Boulan and Sabatini , 1978). other studies have
shown that, in the same cell type, the rate of surface
expression of the NDV and VSV glycoproteins differs
because of differences in transit times between the RER
and the trans golgi (Morrison and Ward, 1984). These
findings suggest that different cellular pathways and/or
host cell factors may be involved in the maturation of
these proteins as well as the virus particles.
Hypothetically, in B cells , these cellular pathways may be
affected by the spectrum of inductive signals a B cell has
received and result in differences in the ability of B
cells to support these different viruses.
using the previously defined system for activating
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B cells to different points in their activation pathway, I
have assessed their ability to support NDV infection
applying the same criteria of infection previously
employed for VSV. I find that the B cell' s ability to
support a productive NDV infection differs markedly from
the requirements necessary to support VSV.
RESULTS
NDV infection of B cell enriched populations
In initial experiments freshly isolated murine
splenic B cell enriched populations were activated with
various stimuli and were then tested for their ability to
support NDV infection and replication. These B cells
95% surface Ig+ by fluorescent staining, were
unelutriated and represented a continuum of activation
states due to in vivo stimulation. Table 9 shows the
number of infectious centers per 103 cells in B cell
populations infected after exposure to different
activators in culture for 24 , 48 , and 72 hours. B cells
cultured with no additional stimulus for 24 and 48 hours
produced 31 and 59 infectious centers , respectively.
These values are used as background levels in this
experiment. This background level of infectious center
'..,,,, ! '
128
formation in B cell enriched populations , also observed
for VSV infection (Table 3), is likely due to infection of
B cells previously activated in vivo Cells cultured in
the presence of splenic SN derived lymphokines show a 2-
fold increase over background levels at these time points.
This increase in NDV infectious centers may result from
lymphokine induced B cell progression into the G1 phase of
the cell cycle and/or result from the ability of
lYmphokines to support further differentiation of B cells
which have been previously activated in vivo It is also
possible that other contaminating cell types in the cell
mixture, such as macrophages , polymorphonuclear
neutrophils, etc., are induced to respond more effecti yely
to NDV infection after lYmphokine exposure or themselves
provided lymphokines that could alter the B cell response.
B cells stimulated with anti-Ig or anti-Ig and lymphokines
(splenic SN) demonstrate the greatest increase. At 48
hours , anti-Ig stimulated cultur s are increased 4-fold
(236 infectious centers) over backgroupd levels while
anti-Ig and lYmphokine stimulated B cells show a 6-fold
increase (347 infectious centers per 103 cells plated)
over background. In contrast, the number of infectious
centers observed in LPS activated cultures was only 2-fold
over background, Le. 125---per 103 cells plated. The
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number of cells producing infectious centers remained
relatively constant between 48 and 72 hours for anti-Ig
and LPS stimulated populations. The NDV permissive murine
B cell line , SP2/0 , produced 420 to 452 infectious centers
per 103 cells plated when used as a control in these
experiments (Table 9 legend).
These data are consistent with an increased
ability to support a productive NDV infection
, at least as
determined by infectious center formation
, as B cells are
stimulated further along their activation/differentiation
pathway. While these experiments demonstrate that B cells
can be activated to support increased numbers of NDV
infectious centers , they do not define specific activation
requirements due to the presence of endogenously activated
B cells and other cell types in the partially purified
populations. To better determine activation requirements
for splenic B cell support of NDV infection, B cells , size
fractionated by elutriation , were used for all subsequent
experiments.
NDV infection of purified small B cell populations
Freshly isolated small resting B cells were
exposed to NDV on the day of isolation (Table 10 A) in
order to fully assess susceptibility to NDV. This B cell
population produced 27 NDV infectious centers per 103
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cells plated. Maintenance of these cells in culture for
24 and 48 hours without further stimulation demonstrated a
slight increase in number of infectious centers
, 52 and 38
per 103 cells plated , respectively. In these unstimulated
B cells the "background levels" for NDV contrast
significantly with the background levels observed for VSV
(between 1 to 4 I. /103 cells plated, Tables 4 and 
when susceptibility to both viruses was assessed in the
same B cell population , clearly suggesting an intrinsic
difference in small B cell support for these two viruses.
stimulation with lymphokines contained in splenic SN
demonstrated no increase over background at 24 hours and a
2-fold increase over background at 48 hours
, up to 86
infectious centers. B cells stimulated for 48 hours with
anti-Ig or LPS prior to infection with NDV demonstrate 5
and 3. 5 fold increases in infectious centers over
background to 210 and 140 infectious centers
respectively.
To determine the full spectrum. of responses to B
cell activators , small B cells were cultured prior to NDV
infection with lymphokines from T helper cell lines
, which
produce both d fferent and more defined collections of
lymphokines upon stimulation with Con A (Mossman et. ale ,
1986) from those found in splenic Con A SN (Table 10 B).
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B cells stimulated with these populations of lymphokines
produced a 2-fold increase in infectious centers over
background , the same as that observed for B cells
stimulated with splenic SN derived lymphokines. Anti-Ig
and LPS demonstrate 3 and 4-fold increases in infectious
centers , respectively.
Data from these experiments with purified B cells
indicate that after 24 hours of stimulation there is no
consistent increase in NDV infectious centers over the
background level for any stimulus tested. After 48 hours
of stimulation the number of NDV infectious centers
increases 2-fold upon stimulation with lYmphokines from a
variety of sources. This lymphokine effect, in general,
may be more apparent than real, as there is little change
in number of infectious centers between 24 and 48 hours
for the lymphokine stimulated B cells, while most of the
change is seen relative to the background level from
unstimulated B cells which drops 2-fold (Table 10). These
results with NDV infection of lymphokine stimulated B
cells are comparable to those observed for VSV infection,
as lYmphokine stimulation did not increase the number of
cells producing VSV infectious centers (Tables 4 and 5).
Activation into S phase of the cell cycle with anti-Ig
further enhances plaque formation up to 5-fold over
.'. ""..
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background and is as effective as LPS stimulation. The
resul ts of these experiments on B cell support of NDV
infection contrast at a couple of levels with B cell
support of VSV where the background level of infectious
center formation was only 1 to 5 per 103 cells plated and
LPS was more effective than anti-Ig stimulation.
In addition to assaying infectious center
formation, the production of infectious NDV particles was
measured from culture SNs obtained 24 hours after
initiation of infection in the bame populations of B
cells. Low levels of PFUs were produced under all
stimulating conditions; less than one PFU per infectious
center was observed when culture SNs from infected
unstimulated, lymphokine stimulated, or LPS activated B
cells and up to 1-2 PFUs per infectious center was seen
with anti-Ig stimulated B cells (Table 10 B). Infection
of murine B cells in general is not apparently the problem
for support of NDV , because infection was found to proceed
normally in the B cell hybridoma, 36-65, and myeloma,
SpJ2 , which produce 15-25 PFU/I.
By the characteristic of PFU production, NDV
infection of B cells differs once again from VSV infection
in that the level of VSV PFU synthesis increases
proportionally to the "inductive stimulus" , as PFU
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production in LPS activated B cellls is equivalent to that
found in permissive cells. Whereas activated B cells
support an increase in numbers of NDV infectious centers
few PFUs are produced or detected from any culture SNs.
The course of NDV infection is locked into the same mode
found in anti-Ig stimulated VSV infected B lymphocytes and
does not transit beyond this step.
A number of possibilities may account for the lack
of PFU detection under conditions of infectious center
formation. Infectious centers may result from NDV F
protein mediated fusion between the B cell and the
permissive indicator monolayer. This fusion event, termed
fusion from within, does not require the synthesis or
release of virions (Gallagher and Bratt, 1976). Fusion of
B cells with the permissive indicator cell could be
mediated by newly synthesized F protein and would allow
infectious plaque formation to be observed even if B cells
are defective at some stage in NDV replication or
maturation of virus particles (stability or release)
because the infection would be fully supported by the
permissive cell monolayer. The possibly that fusion is
mediated by residual F protein from the infecting virus
located on the B cell surface is unlikely due to post-
infection treatment of B cell cultures with anti-NDV s rum
!II '
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as well as by the fact that increases in infectious center
formation are observed with B cell activation , a finding
inconsistent with fusion mediated by input virions.
Another possibility which could account for the lack of
PFU detection is that the proximity of a supportive B cell
and the indicator cell may facilitate detection of virus
particles by infectious center formation if rebinding of
released virions is occuring in the infected B cell
cul tures, thus artifically lowering PFU numbers found free
in culture SNs.
To begin to examine the question of NDV PFU
synthesis , a further examination of NDV particles released
into culture SN was performed. For NDV particles to be
infectious , the newly synthesized viral F glycoprotein in
the Fo (inactive) form must be cleaved to the F1 (active)
form by a cellular enzyme. If this enzYmatic activity is
inefficient or absent in a host cell , non-infectious virus
particles may be produced that would not be detected by
the plaque assay used. It is possible that the required
cellular enzyme is not present or needs to be induced or
upregulated during activation of normal B cells.
enzYmatic activity is low in infected B cells it is
possible that few copies of F protein on the infected cell
surface are in active form. Therefore , contact of an
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infected B cell with the indicator monolayer may permit
more efficient contact with a greater number of cleaved F
protein molecules , thereby facilitating fusion and
subsequent infectious center formation. Al ternati vely 
released virion particles may contain a limited number of
processed F glycoproteins which deters PFU detection.
That B cells , in general , are not lacking in this enzYme
is demonstrated by the observation that the murine
myeloma, Sp2/0 , and the hybridoma, 36-65 , cell lines are
permissive for NDV.
The question of incomplete F protein processing in
virions produced by the B cell populations was analyzed
directly by including trypsin, which cleaves Fo to an
active form, in the media overlay mixture for the plaque
assay (see methods) The data, shown in Table 11
demonstrate no differences in the number of PFUs assayed
either with or without trypsin indicating that the lack of
PFUs detected is not due to incomplete processing of the F
glycoprotein in the B cell populations tested. The
avirulent NDV strain B1 Hitchner , which requires cleavage
of the F protein, was used as a control for this assay
with less than 10 PFU/ml observed without trypsin and 1.
X 106 PFU/ml with trypsin. These results indicate that
the lack of PFU synthesis detected in NDV infected B cell
ip,
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culture occurs at another level in NDV replication.
The lack of PFU synthesis by NDV infected B cells
could be due to limits on infection at a number of levels
such as low level synthesis of a particular viral
,0'
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protein(s) (transcriptional or translational controls),
defects in genomic replication , or virion assembly and
maturation. To begin to study these possibilities, the
'f.
progress of NDV infection was monitered by examination of
!':
viral protein synthesis. NDV viral proteins are observed
in all populations of B cells, when total cell lysates
labeled with 35s-methionine were analyzed (Figure 12).
Freshly isolated resting B lymphocytes (lane 2),
unstimulated cultured B cells (lanes 4 and 14), splenic SN
(lanes 6 and 16), anti-Ig (lanes 8 and 18), and LPS (lanes
10 and 20) activated B cells all support NDV viral protein
synthesis. Lane 12 is from infected 36-65 cells which
served as a control population of supportive cells. The
prominant NDV viral proteins observed in total cell
lysates are NP and P, which co-migrate , and M protein.
The synthesis of both the viral HN and L proteins
can be detected by immunoprecipitation of infected cell
lysates with rabbit anti-NDV serum (Figure 13 A, lanes 1
unstimulated; 2, unstimulated cultured; 4, splenic SN; 6
anti-Ig; 8, LPS; and 10, 36-65) or the HN protein alone by
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using a monoclonal antibody (HN 2a, Figure 13 B, lanes 2
unstimulated 4, unstimulated cultured 6, splenic SN 
anti-Igi 10 , LPSi and 12, 36-65). The cleaved F protein
co-migrates with NP and P in this gel system. In figure
13 A, the inability to detect a unique protein band
migrating between the HN and the NP/P band , where Fo would
migrate, in infected cell lysates compared to uninfected
cells supports the notion that F protein cleavage is not a
likely problem in these B cells. To confirm F protein
synthesis and cleavage a monoclonal antibody to the NDV F
protein , kindly donated by R. Iorio , will be used.
The ability to synthesize NDV viral proteins is
consistent with the possibility that the infectious
centers observed from infected B cell populations are the
consequence of fusion between B cells and the indicator
monolayer. The capacity of unstimulated and lymphokine
stimulated B cells to synthesize NDV proteins but not VSV
proteins (Figure 3) illustrates a level of contrast in B
cell support of these two viruses. NDV protein synthesis
by unstimulated B cells also helps to explain the higher
background level of infectious center formation compared
to VSV infection (Tables 4, 5, and 10). That all
populations of B lymphocytes tested, even freshly
isolated , apparently synthesize all NDV proteins without
1 '
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PFU production suggests a block in virus replication at a
point beyond primary translation. To further characterize
B cell activation requirements for support of NDV
infection, an assessment of lymphokine action on anti-Ig
stimulated B cells was done.
Since stimulation of small resting B cells for 48
hours through the anti-Ig activation pathway appeared to
be as effective as LPS for supporting NDV infection , I
asked whether further differentiation along this
activation pathway facilitated by lymphokines would
, ,
produce a more supportive B cell population, as was the
case for VSV infection. As shown in Table 12 (column -
SN), activation for 48 hours with anti-Ig and lymphokines
from a Th2 T cell clone produced no significant increase
in the number of infectious centers over anti-Ig or LPS
stimulation alone. Furthermore , subsequent culture of
infected B cells for an additional 24 hours with
lymphokines had no further effect on NDV PFU synthesis in
these populations (shown in Table 12 , column +SN) These
results demonstrate that the ability of anti-Ig activated
B cell populations to support a productive NDV infection
is not further enhanced with the additional
differentiation induced by the action of lymphokines.
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DISCUSSION
The experiments presented here demonstrate that
in contrast to VSV, freshly isolated unstimulated small B
cells can support NDV infection , at least so as to produce
infectious centers. This population begins to decline
after 24 hours in culture. B cells activated from the
resting Go state into the G1 phase of the cell cycle with
lYmphokines support , at best , a 2-fold increase in
infectious centers compared to unstimulated cultured B
cells. More likely, this number reflects lYmphokine-
mediated enhancement of B cell viability concurrent with a
loss in viability of unstimulated B cells by 48 hours in
cul ture rather than a direct lymphokine induced increase
in B cell support of NDV. B cells stimulated into the S
phase of the cell cycle with anti-Ig support an increase
in number of NDV infectious centers approximately 5-fold
over that observed in unstimulated B cell populations.
cells activated further along their differentiation
pathway with anti-Ig and lymphokines or LPS support no
further increases in numbers of infectious centers than
that observed with activation by anti-Ig alone. All B
cell populations , even unstimulated B cells , synthesize
NDV viral proteins but fail to produce high levels of PFUs
(Tables 10 and 12). The highest level of PFU synthesis is
140
detected in anti-Ig stimulated B cells, approximately 1
PFU per infectious center. Therefore, while the B cell
activators used in these experiments support an increase
in the number of B cells capable of supporting NDV protein
synthesis, indicated by infectious center formation, no
populations are produced which support a fully permissive
NDV infection, defined here as high level PFU synthesis.
It is possible that the lack of PFUs detected from
cul ture SN of NDV infected B cells is the result of
adsorption of released virus particles by other cells in
cul ture. Infected B cells were cultured overnight (for 24
hours post-infection) in 24 well tissue culture plates at
a cell concentration of approximately 5 x 105/ml (total
volume of 1 ml of media) for the analysis of PFU synthesis
in these exper iments . Al though the ratio of infected
un infected B cells would r main the same , lowering the
cell concentration during the culture time may facilitate
the detection of PFUs by reducing the overall density of
the cultures. Adsorption of virus particles would be,
suggested by finding that 10-fold cell dilutions result in
less than 10-fold reductions in virus titer. It is also
possible that NDV PFU synthesis is delayed in infected B
cell cultures. Therefore, PFU production will be assayed
at 12 hour intervals up to three days post- infection in
. !'
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order to assess the rate of PFU accumulation. Infected B
cell cultures can also be set up under the same
stimulating conditions used prior to infection to see if
additional activation time enhances PFU synthesis.
NDV PFU production by B cells may also be limited
by interferon effects. Interferon may be more effectively
induced in B cells by NDV than VSV infection , subsequently
causing low PFU production. Not only can viruses vary in
their ability to induce interferon (Joklik, 1985), but the
ability of particular host cells, in this case B
lYmphocytes in different activation states , to be induced
to synthesize interferon can vary. Differences in
interferon induction in B cells has been seen, e.g.,
splenic B cells, partially purified by methods which would
retain macrophages, efficiently induce interferon as a
result of stimulation with poly I:C but not LPS (R. Kamin
981) . Whether interferon induction was due to
stimulation of macrophages present in the cell populations
used or was dependent on the B cell state of activation/
differentiation was not addressed in these experiments.
To address the possibility that interferon is responsible
for the low NDV PFU production in my system, anti-
interferon antibodies, specific for alpha,- beta , and gamma
interferon , can be added to the infected B cell cultures
I II
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and SNs subsequently assayed for PFU production.
Increased NDV PFU production by any or all infected B cell
populations treated with antibodies over the level of PFUs
in untreated B cell populations would suggest that
interferon induction by NDV infection results in limited
PFU synthesis.
The general characteristics of NDV infection in
all primary B cell populations tested, viral protein
synthesis with low level synthesis of NDV PFUs, are quite
similar to the characteristics observed when anti-Ig
stimulated B cells are infected by VSV. It is conceivable
that all B cell populations tested are restricted in
support of NDV replication at a point(s) beyond protein
, I
synthesis , such as protein maturation, virus replication,
assembly or release of virus particles and the restriction
may be dependent on the particular activation signals a B
cell population received. Many of the possible
limitations on virus replication previously discussed for
VSV infection of anti-Ig stimulated B cells (chapter 
may apply for NDV infection and are briefly outlined here.
Restriction on PFU synthesis in NDV infected B
cells may be the result of inappropriate maturation of NDV
proteins. While no evidence was seen for lack of
synthesis or incomplete processing of the NDV F
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glycoprotein by the B cell populations tested (Table 11),
a direct examination has not been done. The use of a
monoclonal antibody for immunoprecipi tation will confirm
synthesis as well as enzYmatic processing of the F
protein. Localization of the F protein to the cell
surface for its inclusion into virions can be analyzed by
cell surface staining or with specific immunoprecipitation
of cell surface molecules. Oligomerization of the NDV HN
glycoprotein is also required for inclusion into NDV virus
particles (Schwalbe and Hightower, 1982). Both monomer
and oligomer forms of HN have been shown to be expressed
on the cell surface , but only the oligomer is found in
virus particles (Morrison et. al., 1990). As a method for
studying HN protein processing in B cells, I have
available a number of monoclonal antibodies to the HN
glycoprotein of NDV (kindly provided by Dr. R. Iorio).
These antibodies have been used to study NDV-HN protein
processing both at the level of virion maturation (i. 
the requirement for oligomerization, Mqrrison et. al."
1990) and for the acquisition of antigenic sites during
protein transport and maturation within the cell (T.
Morrison, personal communication). The use of these well
characterized reagents provides a powerful tool to assess
oligomerization, transport , and surface expression of HN
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in B cell populations and should indicate if B cells
restrict NDV infection at these levels.
Another level of restriction to NDV replication in
B cells may occur at the synthesis of positive or negative
genomic RNA strands. Synthesis of full length genomic RNA
is dependent on the synthesis of sufficient nucleocapsid
proteins to signal the RNA dependent RNA polYmerase to
synthesize full length copies of the genome rather than
viral mRAs (review: Kingsbury, 1990). If synthesis of
ei ther form is 1 imi ted , low level PFU production could be
observed. An examination of replicative forms of RNA in
these B cell populations can be done to assess this
possibili ty. To ask this question , a cDNA of the NDV P
gene , kindly provided by T. Morrison , will be cloned into
a bluescript vector containing promoters for T3 or T7
polYmerases, allowing synthesis of probeS
-- 
specific for
each s nse of the genomic RNA. As NDV proteins ar
synthesized in all B cell populations restriction at viral
--- - -
mRA synthesis is not a likely restriction point and I
- -:,
have decided not to analyze each NDV gene. . The use of
single gene probe can be used to determine if NDV
transcription, like VSV is upregulated by lYmphokines.
- .
RNA will be extracted from 'NDV infected B cells at
specific times post-infection and analyzed for the
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presence of posi ti ve and negative-sense genomic RNA as
well as for increases in the synthesis of negative-sense
genomic RNA which are expected at later times of infection
if viral replication is supported by B cells. B cells may
also support the preferential synthesis of defective
interfering genomic forms. RNA can be extracted from
particles released into infected B cell culture SNs and
assessed for synthesis of defective genomic forms by
Northern analysis.
Limi tation on NDV infection in the B cell
populations tested could also be caused by defective or
restricted assembly and maturation of virus particles.
electron microscopic study can be done to examine whether
assembly of viral nucleocapsids occurs in the cell
cytoplasm and to look for association of nucleocapsids
with the cell membrane containing the viral glycoproteins.
Inhibition of release or instability of released particles
is another possibility for the lack of PFU detection from
primary B cells. That instability is not a likely
explanation for the lack of PFUs detected is demonstrated
by the fact that the level of PFUs detected is constant
when assayed either freshly from cell culture or after
freezing of the SNs (data not shown). Inhibition of
release may be suggested by the electron microscopic
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studies if assembly of viral components within the B cell
appears normal. It is also possible that the released
virions contain insufficient amounts of particular viral
proteins required for infectious virus particles. This
possibility can be examined by analyzing the protein
composition of 35S-methionine labeled particles released
into the culture SN from infected B cell cultures and
permissive cells for differences in levels of viral
proteins using SDS gel electrophoresis.
Each of the aforementioned possibilities could
account for the lack of NDV PFU synthesis by the B cell
populations tested. It is possible that the unique
stimulus the B cells have experienced may impose a
different restriction on the viral replicative process.
Protein maturation, genomic replication, or maturation of
virions , can be tested to determine where there is an
impact on NDV infection.
An intriguing aspect of these experiments is the
difference in the ability of primary B cells, activated to
different points in their activation/ differentiation
pathway, to support infection of NDV or VSV. unstimulated
or lymphokine activated B cells support NDV but not VSV
protein synthesis. Anti-Ig stimulated B cells demonstrate
the same level of support for the two viruses , i. e. viral
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protein synthesis and an increase in number of infectious
centers over background but only low level synthesis of
PFUs. Anti-Ig and lymphokine stimulated cells which are
fully permissive for VSV, supporting high levels of PFU
synthesis , only support NDV protein synthesis and low PFU
production. LPS activated cells, which are the most
supportive for VSV both in the number of cells producing
infectious centers as well as PFU synthesis , support NDV
protein synthesis , no further increase in infectious
center formation over that seen with anti-Ig stimulation
and low level of NDV PFU synthesis. These results may
suggest a requirement for different cellular factors by
these two viruses for support of infection and that the
appropriate factors for VSV but not for NDV are induced
during B cell activation by the stimulators used.
The observed differences in level of PFU synthesis
are due to an as yet undefined cellular function and are
not apparently the consequence of the B cell populations
supporting different levels of NDV and VSV viral protein
synthesis. This is seen when aliquots taken from the same
cell populations are infected with either NDV or VSV.
Figure 14 demonstrates that when equivalent amounts of
infected B cell lysates (also equivalent amounts of 35S-
methionine incorporation) are compared the level of
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synthesis of the most prominant viral proteins , the NDV NP
and P proteins or the VSV N and NS proteins , are similar.
These comparable levels of viral protein synthesis are
seen in populations of anti-Ig stimulated B cells which
fail to produce either NDV or VSV PFUs (lanes aIg, N and
V) and in B cell populations stimulated with anti-Ig and
lymphokines which are fully permissive for VSV but not NDV
(lanes aIg +SN , N and V) These results suggest that the
failure of anti-Ig and lymphokine stimulated B cells to
synthesize NDV PFUs is likely due to other host cell
factors influencing the virus infections.
Experimental evidence for the idea that these two
viruses utilize different cellular functions during their
infective process is provided by a number of studies. The
surface glycoproteins of these two virus families are
expressed on opposite cell surfaces in polarized cells
(Rodriquez-Boulan and Sabatini, 1978), and the rate of
surface glycoprotein expression differs when the same cell
type is infected with NDV or VSV (Morrison and Ward
1984) . That B cells can support a productive NDV
infection is shown by the fact that the B cell hybridoma
36-65, or the myeloma, SP2jO support NDV to the same
extent observed for NDV permissive chick embryo
fibroblasts , producing up to 25 PFU per infectious center.
/C'
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This suggests that either the differentiation state of
these B cell lines or the transformation event which
allowed continual growth in culture induced cellular
changes required for high level NDV PFU synthesis.
Al ternati vely, primary B cells may produce host cell
factors which in some way directly inhibit NDV infection
and the loss of expression in these permissive B cell
lines results in enhanced susceptibil i ty to NDV.
One class of host factors that have received a lot
of interest are members of stress protein families. These
proteins have been shown to fulfill some host cell
functions required by a number of viruses to undergo an
infective/replicative process, ex. the heavy chain binding
protein (also called hsp 78 , BiP, or GRP78) is important
for oligomerization of VSV viral glycoprotein (de Silva
et. al., 1990). stress proteins are induced in cells by
normal processes like B cell activation (Spector et. al.
1989; wiest et. al. , 1990) and by virus infection (Sarnow
1989; Young, 1990; Collins and Hightower, 1982; Garry
et. al., 1983). These proteins may have protective
functions for cell survival or in turn may be utilized by
the viruses to support infection (Young, 1990; Sarnow
1990; de Silva et. al., 1990). That NDV and VSV may
utilize different stress proteins is suggested by studies
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that demonstrated that NDV infection of chick embryo cells
induced the synthesis of hsp20 , hsp30 , hsp70 , hsp78 , and
hsp90 proteins (Collins and Hightower , 1982) whereas VSV
infection of the same cell type induced hsp70 and hsp90
proteins (Garry et. al. , 1983). Therefore , it is possible
that the B cell activation regimins used induce the
synthesis of stress proteins which support VSV infection
while either inducing other proteins that directly inhibit
NDV or block the ability of NDV to induce required host
cell proteins. studies that examine the overall
expression of these stress protein families in B cells at
different activation states or induced by different
activators may provide insights into host cell factors
that influence virus infection of B lymphocytes.
. :
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Table and Fiqure Leqends
Table 9
B cell enriched populations were cultured with the
indicated stimulus for 24, 48, or 72 hours prior to NDV
infection. Serial dilutions of infected cells were plated
onto chick embryo fibroblast monolayers , overlayed with 2%
agarosejagar media and plaques counted at 2 and 3 days.
As controls the myeloma Sp2jO produced 452 and 420
infectious cente per 103 cells plated at 24 and 48 hour
time points , respectively, and CHO cells produced 370
infectious centers per 103 cells plated in the 72 hour
, ,
experiment.
. i
number of infectious centers per 103 cells plated,
mean of three serial dilutions
not done
Table 10
Small elutriated B cells we e"9ultured with the
indicated stimulus for 24 or 48 hours pr.ior to infection
with NDV. In experiment A freshly isolated B cells were
also assayed for support of NDV. The hybridoma , 36-65
was used as a- control in these experiments. All values
are per 103 cells assayed- In e periment A 36-65 produced
i':
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, ' r-
152
322 I. C. and 4, 830 PFU at 24 hours and 295 I. c. and 6, 200
PFU at 48 hours. In experiment B 36-65 produced 270 I.
and 3, 900 PFU at 24 hours and 339 I. C. and 7, 800 PFU at 48
hours.
number of infectious center per 103 cells plated, mean
of three serial dilutions
number of PFU per 103 cells cultured, mean of two
serial dilutions
Table 11
Small elutriated B cells were cultured for 48
hours with the indicated stimulus prior to infection.
culture SNs were collected 24 hours post-infection from
infected B cell cultures and were assayed for PFU
production in the presence or absence of trypsin.
control for trypsin activity the NDV avirulent strain B1
Hitchner gave ~10 PFU/ml without trypsin and 1. 7 x 106
PFU/ml with trypsin.
number of PFU per 103 cells cultured, mean of three
serial dilutions
Table 12
Small elutriated B cells were culture with the
indicated stimulus for 48 hours prior to NDV infection.
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Infected B cells were cultured for 24 hours post-infection
in the presence or absence of Th2 T-cell derived
lymphokines (final concentration 50%). As control 36-65
produced 6 470 PFU per 103 cells cultured.
number of infectious center per 103 cells plated, mean
of three serial dilutions
number of PFU per 103 cells culture , mean of three
serial dilutions
Fiqure 12
Small elutriated B cells were infected with NDV on
the day of isolation (lanes 1 and 2), cultured 24 (lanes
3-10), or 48 hours (lanes 13-20) with the indicated
stimulus prior to infection. Cells were labeled with 35S-
methionine in media for 2 hours between 8-10 hours post-
infection , lysed, and equivalent cpm were analyzed on a
10% SDS acrylamide gel. All samples are shown as paired
lanes un infected (odd number lanes) and infected (even
numbers) . The hybridoma , 36-65 , (lanes 11 and 12) was
used as control in each experiment.
Fiqure 13
Immunoprecipitation with rabbit anti-NDV serum (A)
or monoclonal anti-NDV HN 2a (B) were carried out on 35S-
i.'
. "'
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methionine labeled uninfected and infected B cell lysates.
The samples of B cells used were infected after 48 hours
of stimulation except for those in panel A, lane 1 and
panel B, lanes 1 and 2 which were samples of freshly
isolated B cells.
Panel A: samples from B cells in lane 1, unstimulated
freshly isolated and lane 2, unstimulated cultured or B
cells stimulated with lanes 3 and 4 , splenic SN; lanes 5
and 6, anti-Ig; lanes 7 and 8, LPS. Lanes 9 and 10 are
lysates from the hybridoma 36-65. Lanes 3, 5 , 7, and 9
are un infected cell lysates and lanes 1 , 2 , 4, 6 , 8, and
10 are infected cell lysates.
Panel B: Samples from B cells in lanes 1 and 2, freshly
isolated; lanes 3 and 4 , unstimulated cultured; lanes 5
and 6 , splenic SN; lanes 7 and 8 , anti-Ig; lanes 9 and 10
LPS; and lanes 11 and 12, 36-65. Lanes 1, 3, 5 , 7, 9 , and
11 are uninfected cell lysates and lanes 2, 4 , 6, 8 , 10
and 12 are infected cell lysates.
Fiqure 14
Small elutriated B cells were cultured for 48
hours with the indicated stimulus prior to infection and
then 35s-methionine labeled for 2 hours between 8 and 10
hours post-infection. samples from each stimulated
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population were taken for uninfected (U), NDV infected
(N), and VSV infected (V). Equivalent cpm (also
equivalent cell lysates for each stimulus) were loaded for
comparison on a 10% SDS acrylamide gel.
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TABLE 9
INFECTIOUS CENTER ASSAY OF B CELL ENRICHED SPLEEN
CELL POPULATIONS INFECTED WITH NDV AT VARIOUS
TIMES AFTER IN VITRO CULTURE
(per 10 cells plated)
STIMULUS 24 hr. 48 hr. 72 hr.
nd b
SPLENIC SN 106
ANTI- 236 236
ANTI- Ig + SN 347 230
LPS 125 121
. ,
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TABLE 1 0
SMALL RESTING B CELLS CAN BE ACTIVATED TO
PRODUCE INCREASED NUMBERS OF NDV INFECTIOUS CENTERS
WITHOUT SIGNIFICANT PFU PRODUCTION
TIMULU INFECTIO S CENTER PFU
(per 10 cells cultured)(per 10 cells plated)
FRESHL Y ISOLATED
24 hr. 48 hr. 24 hr. 48 hr. I:;
SPLENIC SN
ANTI- 210
LPS 140
Th1 SN (01.
f,-
Th2 SN (CDC 35) 1 0
ANTI-
LPS
9'- . r
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TABLE 11
F PROTEIN CLEAVAGE DEFECTS IN B CELLS
DO NOT ACCOUNT FOR LOW PFU PRODUCTION
PFU
(per 10 cells cultured)
yps yps
Th2 SN 1 1
ANTI- 130 147
ANTI- Ig + SN
LPS
1 1
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TABLE 12
NDV PFU PRODUCTION BY INFECTED ANTI- Ig STIMULATED
B CELLS IS NOT ENHANCED BY CO-CULTURE WITH L YMPHOKINES
PFU
(per 10 cells cultured)
STIMULUS +SN
t-E
Th2 SN
ANTI- 130 165
ANTI- Ig + SN 116
LPS
' , , ,
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CHAPTER 5
DISCUSSION
In this dissertation, I describe an experimental
system which provides for an analysis of the ability of
primary B lymphocytes in different activation states or
exposed to different activators to function as host cells
for virus infection. Because transformed B cell lines
representing different stages of B cell differentiation
exhibited levels of virus support not seen in primary B
cell populations at equivalent differentiation stages,
primary B cells were considered the most appropriate model
for analysis. Because the general requirement for
lymphocyte "activation" for viral PFU production has been
demonstrated by other investigators besides myself , unique
aspects of the association between activation and support
of virus infection are reported here. The progress of VSV
infection in primary B lymphocytes is directly dependent
on their activation state. B cell control on VSV
infection at the translational level was observed in
unstimulated B cells and in lymphokine stimulated B cells,
this latter observation despite the demonstration of
lYmphokine mediated enhancement of viral mRNA
transcription. B cell entry into the S phase of the cell
cycle by anti-Ig stimulation released the translational
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block but still restricted VSV infection as high level PFU
synthesis required B cell stimulation with LPS or co-
stimulation with anti-Ig and lymphokines. Somewhat
surprisingly, none of the B cell stimulators used induced
full support for NDV, when assessed by high level PFU
synthesis , although all populations supported NDV protein
synthesis. These results suggest that complex questions
of translational control and transcriptional regulation
may be addressed in primary cell populations that exist in
functionally distinct cohorts as a consequence of the
activation regimen to which they have been subj ected.
II'
The results of these experiments also suggest that
these two closely related viruses may be dependent on
different cellular factors which are induced for VSV but
not NDV by the B cell activators used or that the process
of infection of B cells by these two viruses induces
di fferent cellular responses , e. g. NDV but not VSV may be
a strong inducer of interferon in B cells (R. Kamin
personal communication). Whatever the mechanism , the
system discussed here predictably activates primary B
cells allowing the further characterization of the process
of infection and host cell factors required by these and
other viruses.
This system also provides a new bioassay for B
41\:
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cell lymphokines. Previously, the activity of lYmphokines
or other B cell activators have been assessed by their
ability to support B cell proliferation and/or antibody
secretion or the induction of antibody isotype switching.
The modulation of virus expression following activation
and/or lYmphokine exposure is a new analytical approach
for the assessment of B cell biochemical capabilities that
are induced as a consequence of different B cell
activators. The finding that anti-Ig or LPS activated B
cell populations have very different responses to the same
. .
populations of lymphokines when assayed for the ability to
support VSV infection illustrates the potential for
detecting previously unknown lymphokine effects on B cells
and the biochemical changes that underlie those effects.
1i.
The contrasting effects of lymphokines observed with anti-
Ig or LPS support the notion that lymphokine receptor
expression and response characteristics are dependent on
the signalling pathway used to trigger B cell activation/
differentiation to antibody secretion or that the
subpopulation of B cells which responds to particular
activation signals , anti-Ig vs. LPS, have intrinsic
differences in lymphokine responsiveness. Further
experiments using defined, recombinant lymphokines in
combination wi th anti Ig or LPS stimulation can be done to
:ij,
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assess the molecular/biochemical consequences of the
expression of particular lymphokine receptors on these
fA-
. .- :
populations of primary B cells.
The analysis of B cell support for VSV infection
can also be used with stimulators that allow for further
dissection of the anti-Ig activation pathway. B cell
activation with both phorbol esters and calcium ionophores
causes phosphatidylinositol breakdown and calcium
mobilization , mimicking the responses of anti-Ig
stimulation in normal B cells , and allows B cell entry
, .
into the S phase of the cell cycle (Klaus et. al., 1986;
Gold et. al. , 1990). Activation with either of these
stimulators alone is not sufficient to induce DNA
synthesis but provides the opportunity to examine whether
either phorbol ester and/or calcium ionophore stimulation
alone will release the VSV translational block. Second
because anti-Ig and lymphokine stimulation produce B cells
fully permissive for VSV, will phorbol esters and/or
calcium ionophores serve the same function when used in
combination with lymphokines? Along this same line of
investigation, other B cell activators which induce the
same initial changes as anti-Ig in B cells can also be
used. Conconavalin A induces B cell entry into the G1
stage of the cell cycle (Hawrylowicz and Klaus , 1984) _and
."-, p!
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antibody to Lyb-2, a B cell differentiation antigen that
is involved in B cell activation, causes B cell entry into
G1 and increased surface Ia expression (Subbarao et. ale ,
1988) . will these inducers support the translation of VSV
mRAs or upon co-stimulation with lymphokines will they
enhance VSV PFU production? The examination of support
for VSV infection may demonstrate biochemical differences
in B cells activated with these stimulators
, either alone
or with lymphokines, and provide further information on
the signalling events required for B cell activation and
antibody secretion.
Addi tionally, studies of the hetergenei ty of B
cell responsiveness to lymphokines and other activators
monitered by their ability to support VSV infection
, can
be extended by examining other populations of B cells.
cells in the CBA/N mouse , which carries the xid defect (x-
chromosome-linked immunodeficiecy) have been used as a
model to assess the function of a distinct B cell
subpopulation (Scher , 1982). As a consequence of genetic
differences in x-linked genes which influence B cell
differentiation , xid B cell responses to activation
signals differ from normal B cells (Cohen et. al., 1985;
Siegel et. al. , 1985; Ono et. al. , 1983; Sprent et. al.
1985; Sprent and Bruce , 1984). Comparing the biological
P."
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properties and ability to support VSV infection by xid and
normal B cell populations may provide further insights
into the process of B cell activation. For example , will
lymphokines stimulate xid B cells to support increased VSV
mRA transcription? Anti-Ig stimulation of xid B cells
induces cell blastogenesis , inositol phospholipid
breakdown and calcium mobilization that is observed with
anti-Ig stimulation of normal B cells but fails to induce
xid B cell entry into the S phase of the cell cycle
(Rigley et. al. , 1989; Sieckman et. al., 1978; Hawrylowicz
1984) . Therefore , does anti-Ig stimulation of xid B cells
release the translational block in VSV infection? Unl ike
anti-Ig, phorbol esters and calcium ionophores stimulate
DNA synthesis in xid B cells , like normal B cells
(Hawrylowicz et. al. , 1984; Klaus et. al. , 1986; Rigley
et. al. , 1989), supporting the idea that anti-Ig activation
signals for xid B cells differ at the leve of signal
transduction from normal B cells (Hawrylowicz et. ale ,
1984; Klaus et. al. , 1986; Rigley et. al. 1989).
analysis of support for VSV infection in xid B cell
populations stimulated with phorbol esters and/or calcium
ionophores may further dissect the activation signal (s)
required for release of the B cell block on VSV mRA
translation.
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stimulation of xid B cells with anti-Ig and
lYmphokines does not induce antibody secretion as in
normal B cells , once again providing an opportunity for
examining the B cell activation signals required for
increased VSV PFU production. Whether co-stimulation of
xid B cells with LPS and lYmphokines will have the same
suppressive effect on VSV PFU production as seen with
normal B cell populations is another potential area of
investigation. These studies on VSV infection of xid B
cells may permit the dissection of B cell activation
signals and provide insights into lymphokine and
activation mediated regulation of B cells that may be
associated with X-linked immunoregulatory elements.
Ly 1+ B cells , a bona fide B cell subpopulation
are of increasing interest because they spontaneously
secrete antibody, including autoantibodies , and are the
predominant phenotype of spontaneous B cell lYmphomas and
leukemias (Braun et. al. , 1986; Hardy and Hayakawa , 1986;
Herzenberg et al. , 1986),- can also b ssessed for their
ability to support VSV infection. This functionally
distinct population of B cells is primarily found in the
peritoneal cavity and, unlike normal B cells , is capable
of self-renewal from Ig+ precursors and may also be
undergoing cell cycling. These characteristics suggest
t .
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that Ly 1+ B cells exist in a different activation state
with different biochemical capabilities than splenic B
cells. Because Ly 1+ B cells are capable of self renewal,
will they support VSV infection without additional
stimulation? Since Ly 1+' B cells may be cycling, will
lYmphokine stimulation alone result in a fully permissive
cell population for VSV or permit translation of VSV
proteins? While normal B cells require both phorbol
esters and calcium ionophore stimulation to enter S phase
of the cell cycle , stimulation with phorbol esters alone
is sufficient for Ly 1+ B cells (Rothstein and Kolber
1988) . Will phorbol ester activated Ly 1+ B cells
, which
have entered S of the cell cycle , permit synthesis of VSV
proteins? Lymphokines have also been shown to affect Ly
1+ B cell responses , e.g. IL-4 enhances peritoneal B cell
stimulation induced by phorbol esters (Rothstein
, 1989).
Therefore , what effect will lymphokines have on VSV
support by phorbol ester activated Ly 1+ B cells?
examination of the ability of Ly 1+ B cells to support
virus infection , with or wi thout activation or
lymphokines , provides another means for assessing the
biochemical capabilities and regulation of this distinct B
cell subpopulation that is associated with lymphomas and
autoimmune disease.
;1'.-
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Finally, this system of B cell activation can be
used to assess the B cell support for other viruses which
directly infect mice and use B lymphocytes as hosts. This
system can also be extended to viruses which require a
receptor that is not expressed on murine cells by using
transgenic mouse models to change virus tropisms. For
example , poliovirus has been demonstrated to infect human
lymphocytes , and virus replication is enhanced by
lymphocyte activation (Okada et. al., 1987; Willems et. al.
1969) . The poliovirus receptor has been cloned, and a
transgenic mouse has been made for study (Mendelsohn
et. al., 1989; M. Chow, personal communication. The use of
primary B cells rather than transformed cell lines
provides a model for the study of inducible biochemical
changes effecting host cell/virus requirements for
infection.
In summary, this experimental system provides the
opportunity to study primary B lymphocytes as host cells
for viruses as well as being able to study activation
induced changes in the biochemistry of B cells by assaying
support for virus infection.
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